{\rtf1\ansi\deff0 
{\fonttbl {\f0\fmodern Courier New;}
{\colortbl;\red0\green0\blue0;}
}
\deflang1033\margl1450\margr360\margt1170\margb360\fs14\sl-180\slmult0\landscape\paperw15840\paperh12240
1                                                          The SAS System                           17:57 Monday, September 20, 2010
\par 
\par NOTE: Copyright (c) 2002-2008 by SAS Institute Inc., Cary, NC, USA.
\par NOTE: SAS (r) Proprietary Software 9.2 (TS1M0)
\par       Licensed to SOCIAL & SCIENTIFIC SYSTEMS INC/AHRQ3, Site 0070086875.
\par NOTE: This session is executing on the XP_PRO  platform.
\par 
\par 
\par 
\par NOTE: SAS initialization used:
\par       real time           0:00.35
\par       user cpu time       0:00.06
\par       system cpu time     0:00.28
\par       Memory                            2948k
\par       OS Memory                         3812k
\par       Timestamp            9/20/2010  5:57:07 PM
\par 
\par 
\par NOTE: AUTOEXEC processing beginning; file is C:\\PROGRA~1\\SAS92\\SASFOU~1\\9.2\\autoexec.sas.
\par 
\par 
\par NOTE: AUTOEXEC processing completed.
\par 
\par 1          %JOBSTART;
\par |~~~~~~~~~~~~~~~~~~~~~~~~|
\par | JOB ID      : 7479     |
\par | DATE        : 09/20/10 |
\par | START TIME  : 17:57:07 |
\par |~~~~~~~~~~~~~~~~~~~~~~~~|
\par 2
\par 3          ODS NOPROCTITLE;
\par 4          OPTIONS LS=155 PS=55;
\par 5          ***********************************************************************************************
\par 6          Software Version:   9.2
\par 7          Creation Date:      2008-08-29
\par 8          Task:               AH3.FD001
\par 9          Task Title:         2007 Prescribed Medicines Event PUF
\par 10
\par 11         Program Name: AHRQ3\\F_DSO\\FD001NKK\\PROG\\TOP25RX07_EXP.SAS
\par 12
\par 13         Description:  Produce estimates with standard errors of top 25 drugs in 2007
\par 14                       by weighted expenditures for the Tables Compendia on the Web.
\par 15                       Produce Z-scores comparing weighted expenditures of
\par 16                       top 25 drugs to each other.
\par 17
\par 18                       Output the table statistics and formats in order to convert tables to HTML format.
\par 19
\par 20         Reference:    Marie Stagnitti / Nancy Kieffer
\par 21                       Stagnitti's email dated 4/30/07 - Do top 25 instead of top 10
\par 22                       Phone coversation with Marie 11/6/07: Rank using non-confidential data
\par 23                       Stagnitti's email dated 10/23/08 - asterisk for outlier drug
\par 24
\par 25         Input file:   AHRQ3\\F_DSO\\FD001NKK\\DATA\\RX07V06.SAS7BDAT
\par 26                       AHRQPUF\\HCPUFS\\HC107\\DATA\\H107V1.SAS7BDAT
\par 27                       AHRQ3\\BC002XXX\\DATA\\MEPSHC2008\\D082410\\PERWT08F_ADJ.SAS7BDAT
\par \page 2                                                                     The SAS System                                       17:57 Monday, September 20, 2010
\par 
\par 28                                                           (Final expenditure person level weight)
\par 29
\par 30         Output file:  AHRQ3\\F_DSO\\FD001NKK\\DATA\\FMTLIB\\RX07_EXPFMT.SAS7BCAT
\par 31                       AHRQ3\\F_DSO\\FD001NKK\\DATA\\TABLES\\TOP10RX07_EXP.SAS7BDAT
\par 32
\par 33         Programmer:   Nancy Kieffer
\par 34
\par 35         Update History:  Blaine Byars
\par 36         							2009-08-08 Use updated VARSTR/VARPSU
\par 37         **********************************************************************************************;
\par 38         %LET YY=08;
\par 39         %LET FYPUF=H115V1;     /* FY Person Characteristics PUF file name   */
\par 40         %LET FYNUM=115;        /* FY Person Characteristics PUF file number */
\par 41
\par 42         LIBNAME RXPUF "c:\\AHRQ3\\F_DSO\\FD001NKK\\DATA";
\par NOTE: Libref RXPUF was successfully assigned as follows:
\par       Engine:        V9
\par       Physical Name: c:\\AHRQ3\\F_DSO\\FD001NKK\\DATA
\par 43         LIBNAME RXTAB "c:\\AHRQ3\\F_DSO\\FD001NKK\\DATA\\TABLES";
\par NOTE: Libref RXTAB was successfully assigned as follows:
\par       Engine:        V9
\par       Physical Name: c:\\AHRQ3\\F_DSO\\FD001NKK\\DATA\\TABLES
\par 44         LIBNAME RXFMT "c:\\AHRQ3\\F_DSO\\FD001NKK\\DATA\\FMTLIB";
\par NOTE: Libref RXFMT was successfully assigned as follows:
\par       Engine:        V9
\par       Physical Name: c:\\AHRQ3\\F_DSO\\FD001NKK\\DATA\\FMTLIB
\par 45         LIBNAME WGT "C:\\AHRQ3\\BC002XXX\\DATA\\MEPSHC2008\\D082410";
\par NOTE: Libref WGT was successfully assigned as follows:
\par       Engine:        V9
\par       Physical Name: C:\\AHRQ3\\BC002XXX\\DATA\\MEPSHC2008\\D082410
\par 46         LIBNAME FYPUF "C:\\AHRQPUF\\HCPUFS\\HC&FYNUM\\DATA";
\par NOTE: Libref FYPUF was successfully assigned as follows:
\par       Engine:        V9
\par       Physical Name: C:\\AHRQPUF\\HCPUFS\\HC115\\DATA
\par 47         /*LIBNAME VARSTR "C:\\AHRQ2\\BA002XXX\\Data\\WGTS\\D072409";   2007 only */
\par 48
\par 49         OPTIONS FMTSEARCH=(RXFMT.RX&YY._EXPFMT);
\par 50
\par 51         TITLE1 "Task AH3.FD001: 20&YY Prescribed Medicines Event PUF";
\par 52
\par 53         *---------------------------------------------------------------------------------------------
\par 54         * Add final person-level weight to all FY persons and subset to persons with positive weight.
\par 55         * File will be used in SUDAAN to read in the full FY sample.
\par 56         *---------------------------------------------------------------------------------------------;
\par 57         PROC SORT DATA=FYPUF.&FYPUF (KEEP=PERSID VARSTR VARPSU READ=&PWD)
\par 58                    OUT=FYPUF;
\par 59           BY PERSID;
\par 60         RUN;
\par 
\par NOTE: There were 33066 observations read from the data set FYPUF.H115V1.
\par NOTE: The data set WORK.FYPUF has 33066 observations and 3 variables.
\par NOTE: PROCEDURE SORT used (Total process time):
\par       real time           0:00.73
\par \page 3                                                                     The SAS System                                       17:57 Monday, September 20, 2010
\par 
\par       user cpu time       0:00.62
\par       system cpu time     0:00.09
\par       Memory                            2091k
\par       OS Memory                         6636k
\par       Timestamp            9/20/2010  5:57:07 PM
\par 
\par 
\par 61
\par 62         PROC SORT DATA=WGT.PERWT&YY.F_ADJ(KEEP=PERSID PERWT_ADJ2 RENAME=(PERWT_ADJ2=PERWT&YY.F))
\par 63                    OUT=PERWT;
\par 64           BY PERSID;
\par 65         RUN;
\par 
\par NOTE: There were 50092 observations read from the data set WGT.PERWT08F_ADJ.
\par NOTE: The data set WORK.PERWT has 50092 observations and 2 variables.
\par NOTE: PROCEDURE SORT used (Total process time):
\par       real time           0:00.04
\par       user cpu time       0:00.04
\par       system cpu time     0:00.00
\par       Memory                            2420k
\par       OS Memory                         7924k
\par       Timestamp            9/20/2010  5:57:07 PM
\par 
\par 
\par 66
\par 67         /*For 2007, a special update of VARSTR, VARPSU was delivered;
\par 68         PROC SORT DATA=VARSTR.p11p12varstr_v2 (KEEP=PERSID VARSTR VARPSU )
\par 69                    OUT=VARSTR;
\par 70           BY PERSID;
\par 71         RUN;*/
\par 72
\par 73         DATA FYPERS;
\par 74           MERGE FYPUF (IN=A)
\par 75                 PERWT (IN=B)
\par 76                 /*VARSTR (IN=INVARSTR)*/
\par 77                 END=EOF;
\par 78           BY PERSID;
\par 79
\par 80           C1 + (A AND NOT B);
\par 81           C2 + (B AND NOT A);
\par 82           C3 + (A AND B);
\par 83           /*V3 + (A AND B AND INVARSTR); */
\par 84
\par 85           IF EOF THEN DO;
\par 86              PUT "IN FYPUF ONLY:  " C1;
\par 87              PUT "IN WEIGHT FILE ONLY: " C2;
\par 88              PUT "IN BOTH:        " C3;
\par 89              /*PUT "IN FYPUF & WEIGHT FILE & NEW VARSTR: " V3;*/
\par 90           END;
\par 91
\par 92           IF A and PERWT&YY.F > 0;
\par 93           DROP C1 C2 C3;
\par 94         RUN;
\par \page 4                                                                     The SAS System                                       17:57 Monday, September 20, 2010
\par 
\par 
\par IN FYPUF ONLY:  0
\par IN WEIGHT FILE ONLY: 17026
\par IN BOTH:        33066
\par NOTE: There were 33066 observations read from the data set WORK.FYPUF.
\par NOTE: There were 50092 observations read from the data set WORK.PERWT.
\par NOTE: The data set WORK.FYPERS has 31262 observations and 4 variables.
\par NOTE: DATA statement used (Total process time):
\par       real time           0:00.03
\par       user cpu time       0:00.03
\par       system cpu time     0:00.00
\par       Memory                            1397k
\par       OS Memory                         8452k
\par       Timestamp            9/20/2010  5:57:07 PM
\par 
\par 
\par 95
\par 96
\par 97         *----------------------------------------------------------------------------------------------
\par 98         * Subset PMED PUF to persons with positive weights.
\par 99         *----------------------------------------------------------------------------------------------;
\par 100        DATA PMEDS;
\par 101          SET RXPUF.RX&YY.V06 (KEEP=PERSID PERWT&YY.F VARPSU VARSTR PARTITIO_WEB PARTMED_WEB RXXP&YY.X);
\par 102          IF PERWT&YY.F > 0;
\par 103        RUN;
\par 
\par NOTE: There were 293379 observations read from the data set RXPUF.RX08V06.
\par NOTE: The data set WORK.PMEDS has 287606 observations and 7 variables.
\par NOTE: DATA statement used (Total process time):
\par       real time           0:00.53
\par       user cpu time       0:00.17
\par       system cpu time     0:00.34
\par       Memory                            28214k
\par       OS Memory                         36532k
\par       Timestamp            9/20/2010  5:57:08 PM
\par 
\par 
\par 104
\par 105        *---------------------------------------------------------------------------------------
\par 106        * Sum weighted expenditures by non-missing medicine name partition groups.
\par 107        *---------------------------------------------------------------------------------------;
\par 108        PROC SORT DATA=PMEDS;
\par 109        	 BY PARTITIO_WEB;
\par 110        RUN;
\par 
\par NOTE: There were 287606 observations read from the data set WORK.PMEDS.
\par NOTE: The data set WORK.PMEDS has 287606 observations and 7 variables.
\par NOTE: PROCEDURE SORT used (Total process time):
\par       real time           0:00.31
\par       user cpu time       0:00.46
\par       system cpu time     0:00.09
\par       Memory                            64935k
\par       OS Memory                         101768k
\par \page 5                                                                     The SAS System                                       17:57 Monday, September 20, 2010
\par 
\par       Timestamp            9/20/2010  5:57:08 PM
\par 
\par 
\par 111
\par 112        PROC SUMMARY DATA=PMEDS (WHERE=(PARTITIO_WEB NE .));
\par 113          BY PARTITIO_WEB;
\par 114          VAR RXXP&YY.X;
\par 115          WEIGHT PERWT&YY.F;
\par 116          OUTPUT OUT=PARTSUM SUM=RXEXPSUM;
\par 117        RUN;
\par 
\par NOTE: There were 286505 observations read from the data set WORK.PMEDS.
\par       WHERE PARTITIO_WEB not = .;
\par NOTE: The data set WORK.PARTSUM has 1839 observations and 4 variables.
\par NOTE: PROCEDURE SUMMARY used (Total process time):
\par       real time           0:00.14
\par       user cpu time       0:00.11
\par       system cpu time     0:00.03
\par       Memory                            1057k
\par       OS Memory                         37844k
\par       Timestamp            9/20/2010  5:57:09 PM
\par 
\par 
\par 118
\par 119        *-------------------------------------------------------------------------------
\par 120        * Sort partition groups in descending order by weighted expenditures.
\par 121        * Assign rank to non-missing PARTITIO_WEB.
\par 122        *-------------------------------------------------------------------------------;
\par 123        PROC SORT DATA=PARTSUM;
\par 124        	 BY DESCENDING RXEXPSUM;
\par 125        RUN;
\par 
\par NOTE: There were 1839 observations read from the data set WORK.PARTSUM.
\par NOTE: The data set WORK.PARTSUM has 1839 observations and 4 variables.
\par NOTE: PROCEDURE SORT used (Total process time):
\par       real time           0:00.00
\par       user cpu time       0:00.00
\par       system cpu time     0:00.00
\par       Memory                            266k
\par       OS Memory                         37044k
\par       Timestamp            9/20/2010  5:57:09 PM
\par 
\par 
\par 126
\par 127        DATA PARTRANK;
\par 128          SET PARTSUM (KEEP=PARTITIO_WEB);
\par 129          RANK=_N_;
\par 130        RUN;
\par 
\par NOTE: There were 1839 observations read from the data set WORK.PARTSUM.
\par NOTE: The data set WORK.PARTRANK has 1839 observations and 2 variables.
\par NOTE: DATA statement used (Total process time):
\par       real time           0:00.00
\par \page 6                                                                     The SAS System                                       17:57 Monday, September 20, 2010
\par 
\par       user cpu time       0:00.00
\par       system cpu time     0:00.00
\par       Memory                            244k
\par       OS Memory                         37044k
\par       Timestamp            9/20/2010  5:57:09 PM
\par 
\par 
\par 131
\par 132        *--------------------------------------------------------------------------------
\par 133        * Merge RANK onto PMEDs. Recode all ranks > 25 & missing ranks into RANK=26.
\par 134        * For ranks not in top 25, set their PARTITIO_WEB medicine name to "all others".
\par 135        * RANK will be missing for those records where PARTITIO_WEB is missing.
\par 136        *--------------------------------------------------------------------------------;
\par 137        PROC SORT DATA=PARTRANK;
\par 138        	 BY PARTITIO_WEB;
\par 139        RUN;
\par 
\par NOTE: There were 1839 observations read from the data set WORK.PARTRANK.
\par NOTE: The data set WORK.PARTRANK has 1839 observations and 2 variables.
\par NOTE: PROCEDURE SORT used (Total process time):
\par       real time           0:00.00
\par       user cpu time       0:00.00
\par       system cpu time     0:00.00
\par       Memory                            241k
\par       OS Memory                         37044k
\par       Timestamp            9/20/2010  5:57:09 PM
\par 
\par 
\par 140
\par 141        DATA PMEDS;
\par 142          MERGE PMEDS
\par 143                PARTRANK;
\par 144          BY PARTITIO_WEB;
\par 145
\par 146          IF RANK > 25 OR RANK=. THEN DO;
\par 147             RANK = 26;
\par 148             PARTMED_WEB = "All Others";
\par 149          END;
\par 150        RUN;
\par 
\par NOTE: There were 287606 observations read from the data set WORK.PMEDS.
\par NOTE: There were 1839 observations read from the data set WORK.PARTRANK.
\par NOTE: The data set WORK.PMEDS has 287606 observations and 8 variables.
\par NOTE: DATA statement used (Total process time):
\par       real time           0:00.20
\par       user cpu time       0:00.15
\par       system cpu time     0:00.04
\par       Memory                            30086k
\par       OS Memory                         67204k
\par       Timestamp            9/20/2010  5:57:09 PM
\par 
\par 
\par 151
\par \page 7                                                                     The SAS System                                       17:57 Monday, September 20, 2010
\par 
\par 152        *--------------------------------------------------------------------------------------
\par 153        * Create dummy variable to identify unique persons in RANK.
\par 154        *--------------------------------------------------------------------------------------;
\par 155        PROC SORT DATA=PMEDS;
\par 156        	 BY RANK PERSID;
\par 157        RUN;
\par 
\par NOTE: There were 287606 observations read from the data set WORK.PMEDS.
\par NOTE: The data set WORK.PMEDS has 287606 observations and 8 variables.
\par NOTE: PROCEDURE SORT used (Total process time):
\par       real time           0:00.32
\par       user cpu time       0:00.50
\par       system cpu time     0:00.10
\par       Memory                            71097k
\par       OS Memory                         111068k
\par       Timestamp            9/20/2010  5:57:09 PM
\par 
\par 
\par 158
\par 159        DATA PMEDS;
\par 160          SET PMEDS;
\par 161          BY RANK PERSID;
\par 162
\par 163          IF FIRST.PERSID
\par 164           THEN RANKPERS=1;
\par 165           ELSE RANKPERS=0;
\par 166
\par 167        RUN;
\par 
\par NOTE: There were 287606 observations read from the data set WORK.PMEDS.
\par NOTE: The data set WORK.PMEDS has 287606 observations and 9 variables.
\par NOTE: DATA statement used (Total process time):
\par       real time           0:00.17
\par       user cpu time       0:00.14
\par       system cpu time     0:00.03
\par       Memory                            31804k
\par       OS Memory                         72148k
\par       Timestamp            9/20/2010  5:57:09 PM
\par 
\par 
\par 168        				
\par 169        *---------------------------------------------------------------------------------
\par 170        * Create format for RANK by crossing RANK with PARTMED_WEB.
\par 171        *---------------------------------------------------------------------------------;
\par 172        PROC FREQ DATA=PMEDS;
\par 173          TABLES RANK*PARTMED_WEB / LIST OUT=RANKFREQ;
\par 174          TITLE3 "Verification of RANK by medicine name";
\par 175          TITLE5 "RANK based on weighted expenditures";
\par 176          FOOTNOTE1 "Source file: AHRQ3\\F_DSO\\FD001NKK\\DATA\\RX&YY.V06.SAS7BDAT";
\par 177          FOOTNOTE2 "PERWT&YY.F > 0";
\par 178        RUN;
\par 
\par NOTE: There were 287606 observations read from the data set WORK.PMEDS.
\par \page 8                                                                     The SAS System                                       17:57 Monday, September 20, 2010
\par 
\par NOTE: The data set WORK.RANKFREQ has 26 observations and 4 variables.
\par NOTE: The PROCEDURE FREQ printed page 1.
\par NOTE: PROCEDURE FREQ used (Total process time):
\par       real time           0:00.18
\par       user cpu time       0:00.17
\par       system cpu time     0:00.01
\par       Memory                            1361k
\par       OS Memory                         43048k
\par       Timestamp            9/20/2010  5:57:10 PM
\par 
\par 
\par 179
\par 180        DATA FMTDRUGS (KEEP=FMTNAME START LABEL TYPE);
\par 181          SET RANKFREQ END=EOF;
\par 182
\par 183          LENGTH FMTNAME $8 START $2 LABEL $45;
\par 184
\par 185          FMTNAME="RANKFMT";
\par 186          START=PUT(RANK,2.);
\par 187          NUMLABEL=TRIM(PUT(RANK,8.));
\par 188          TYPE="N";
\par 189
\par 190          LABEL=NUMLABEL || " " || PARTMED_WEB;
\par 191          LABEL=LEFT(RIGHT(LABEL));
\par 192          OUTPUT;
\par 193
\par 194          IF EOF THEN DO; /* Total line for tables */
\par 195             START="99";
\par 196             LABEL="TOTAL";
\par 197             LABEL=LEFT(RIGHT(LABEL));
\par 198             OUTPUT;
\par 199          END;
\par 200        RUN;
\par 
\par NOTE: There were 26 observations read from the data set WORK.RANKFREQ.
\par NOTE: The data set WORK.FMTDRUGS has 27 observations and 4 variables.
\par NOTE: DATA statement used (Total process time):
\par       real time           0:00.00
\par       user cpu time       0:00.00
\par       system cpu time     0:00.00
\par       Memory                            227k
\par       OS Memory                         42764k
\par       Timestamp            9/20/2010  5:57:10 PM
\par 
\par 
\par 201
\par 202        PROC SORT DATA=FMTDRUGS;
\par 203        	 BY START;
\par 204        RUN;
\par 
\par NOTE: There were 27 observations read from the data set WORK.FMTDRUGS.
\par NOTE: The data set WORK.FMTDRUGS has 27 observations and 4 variables.
\par NOTE: PROCEDURE SORT used (Total process time):
\par \page 9                                                                     The SAS System                                       17:57 Monday, September 20, 2010
\par 
\par       real time           0:00.01
\par       user cpu time       0:00.01
\par       system cpu time     0:00.00
\par       Memory                            110k
\par       OS Memory                         42764k
\par       Timestamp            9/20/2010  5:57:10 PM
\par 
\par 
\par 205
\par 206        PROC PRINT DATA=FMTDRUGS;
\par 207          TITLE3 "Verification of creating formats for variable RANK";
\par 208          TITLE5 "WORK.FMTDRUGS: Input Control Dataset used to create permanent format for RANK";
\par 209          FOOTNOTE1;
\par 210        RUN;
\par 
\par NOTE: There were 27 observations read from the data set WORK.FMTDRUGS.
\par NOTE: The PROCEDURE PRINT printed page 2.
\par NOTE: PROCEDURE PRINT used (Total process time):
\par       real time           0:00.00
\par       user cpu time       0:00.00
\par       system cpu time     0:00.00
\par       Memory                            98k
\par       OS Memory                         42764k
\par       Timestamp            9/20/2010  5:57:10 PM
\par 
\par 
\par 211
\par 212        PROC FORMAT LIBRARY=RXFMT.RX&YY._EXPFMT CNTLIN=FMTDRUGS FMTLIB;
\par NOTE: Format RANKFMT is already on the library.
\par NOTE: Format RANKFMT has been written to RXFMT.RX08_EXPFMT.
\par 213          TITLE3 "Contents of permanent format library for RANK";
\par 214          FOOTNOTE1 "c:\\AHRQ3\\F_DSO\\FD001NKK\\DATA\\FMTLIB\\RX&YY._EXPFMT";
\par 215        RUN;
\par 
\par NOTE: PROCEDURE FORMAT used (Total process time):
\par       real time           0:00.01
\par       user cpu time       0:00.00
\par       system cpu time     0:00.01
\par       Memory                            216k
\par       OS Memory                         42764k
\par       Timestamp            9/20/2010  5:57:10 PM
\par 
\par NOTE: There were 27 observations read from the data set WORK.FMTDRUGS.
\par NOTE: The PROCEDURE FORMAT printed page 3.
\par 
\par 216
\par 217        PROC FREQ DATA=PMEDS;
\par 218          TABLES RANK / MISSING;
\par 219          FORMAT RANK RANKFMT.;
\par 220          TITLE3 "Unweighted formatted frequency of RANK";
\par 221          TITLE5 "RANK based on weighted expenditures";
\par 222          FOOTNOTE1;
\par 223        RUN;
\par \page 10                                                                    The SAS System                                       17:57 Monday, September 20, 2010
\par 
\par 
\par NOTE: There were 287606 observations read from the data set WORK.PMEDS.
\par NOTE: The PROCEDURE FREQ printed page 4.
\par NOTE: PROCEDURE FREQ used (Total process time):
\par       real time           0:00.06
\par       user cpu time       0:00.06
\par       system cpu time     0:00.00
\par       Memory                            499k
\par       OS Memory                         43048k
\par       Timestamp            9/20/2010  5:57:10 PM
\par 
\par 
\par 224
\par 225        PROC FREQ DATA=PMEDS;
\par 226          TABLES RANK / MISSING;
\par 227          WEIGHT PERWT&YY.F;
\par 228          FORMAT RANK RANKFMT.;
\par 229          TITLE3 "Weighted formatted frequency of RANK";
\par 230          TITLE5 "RANK based on weighted expenditures";
\par 231        RUN;
\par 
\par NOTE: There were 287606 observations read from the data set WORK.PMEDS.
\par NOTE: The PROCEDURE FREQ printed page 5.
\par NOTE: PROCEDURE FREQ used (Total process time):
\par       real time           0:00.07
\par       user cpu time       0:00.07
\par       system cpu time     0:00.00
\par       Memory                            499k
\par       OS Memory                         43048k
\par       Timestamp            9/20/2010  5:57:10 PM
\par 
\par 
\par 232
\par 233        *------------------------------------------------------------------------------------
\par 234        * Produce SAS table.
\par 235        *------------------------------------------------------------------------------------;
\par 236        PROC SUMMARY DATA=PMEDS MISSING;
\par 237          CLASSES RANK;
\par 238          VAR RXXP&YY.X RANKPERS;
\par 239          WEIGHT PERWT&YY.F;
\par 240          OUTPUT OUT=SASTABLE SUMWGT=POPEST SUM=SUMRXEXP SUMPERS;
\par 241        RUN;
\par 
\par NOTE: There were 287606 observations read from the data set WORK.PMEDS.
\par NOTE: The data set WORK.SASTABLE has 27 observations and 6 variables.
\par NOTE: PROCEDURE SUMMARY used (Total process time):
\par       real time           0:00.15
\par       user cpu time       0:00.23
\par       system cpu time     0:00.01
\par       Memory                            7032k
\par       OS Memory                         49460k
\par       Timestamp            9/20/2010  5:57:10 PM
\par 
\par \page 11                                                                    The SAS System                                       17:57 Monday, September 20, 2010
\par 
\par 
\par 242
\par 243        DATA SASTABLE;
\par 244          SET SASTABLE;
\par 245          IF RANK=. THEN RANK=99; /* Total line */
\par 246        RUN;
\par 
\par NOTE: There were 27 observations read from the data set WORK.SASTABLE.
\par NOTE: The data set WORK.SASTABLE has 27 observations and 6 variables.
\par NOTE: DATA statement used (Total process time):
\par       real time           0:00.00
\par       user cpu time       0:00.00
\par       system cpu time     0:00.00
\par       Memory                            185k
\par       OS Memory                         44300k
\par       Timestamp            9/20/2010  5:57:10 PM
\par 
\par 
\par 247
\par 248        PROC SORT DATA=SASTABLE;
\par 249        	 BY RANK;
\par 250        RUN;
\par 
\par NOTE: There were 27 observations read from the data set WORK.SASTABLE.
\par NOTE: The data set WORK.SASTABLE has 27 observations and 6 variables.
\par NOTE: PROCEDURE SORT used (Total process time):
\par       real time           0:00.00
\par       user cpu time       0:00.00
\par       system cpu time     0:00.00
\par       Memory                            88k
\par       OS Memory                         44044k
\par       Timestamp            9/20/2010  5:57:10 PM
\par 
\par 
\par 251
\par 252        PROC PRINT DATA=SASTABLE NOOBS SPLIT="*";
\par 253          VAR RANK _FREQ_ POPEST SUMRXEXP SUMPERS;
\par 254          LABEL RANK    = "Drug*Rank &*Name"
\par 255                _FREQ_  = "Drug*Mentions*Unweighted"
\par 256                POPEST  = "Drug*Mentions*Weighted"
\par 257                SUMRXEXP= "Dollars*Spent*Weighted"
\par 258                SUMPERS = "Count of*Persons*Weighted";
\par 259          FORMAT RANK RANKFMT.;
\par 260          FORMAT _FREQ_ COMMA8.;
\par 261          FORMAT POPEST COMMA20.;
\par 262          FORMAT SUMRXEXP COMMA20.;
\par 263          FORMAT SUMPERS COMMA15.;
\par 264          TITLE3 "Utilization and Expenditures for the Top 25 Prescribed Medicines";
\par 265          TITLE5 "Ranked by Weighted Expenditures";
\par 266          TITLE7 "SAS Output";
\par 267          FOOTNOTE1 "Source file: AHRQ3\\F_DSO\\FD001NKK\\DATA\\RX&YY.V06.SAS7BDAT";
\par 268          FOOTNOTE2 "PERWT&YY.F > 0";
\par 269        RUN;
\par \page 12                                                                    The SAS System                                       17:57 Monday, September 20, 2010
\par 
\par 
\par NOTE: There were 27 observations read from the data set WORK.SASTABLE.
\par NOTE: The PROCEDURE PRINT printed page 6.
\par NOTE: PROCEDURE PRINT used (Total process time):
\par       real time           0:00.01
\par       user cpu time       0:00.00
\par       system cpu time     0:00.01
\par       Memory                            139k
\par       OS Memory                         44044k
\par       Timestamp            9/20/2010  5:57:10 PM
\par 
\par 
\par 270
\par 271        *--------------------------------------------------------------------------------------
\par 272        * Bring in all persons from FY PUF for SUDAAN.
\par 273        * Flag persons with PMEDs.
\par 274        *--------------------------------------------------------------------------------------;
\par 275        PROC SORT DATA=PMEDS;
\par 276        	 BY PERSID;
\par 277        RUN;
\par 
\par NOTE: There were 287606 observations read from the data set WORK.PMEDS.
\par NOTE: The data set WORK.PMEDS has 287606 observations and 9 variables.
\par NOTE: PROCEDURE SORT used (Total process time):
\par       real time           0:00.29
\par       user cpu time       0:00.37
\par       system cpu time     0:00.06
\par       Memory                            73155k
\par       OS Memory                         116764k
\par       Timestamp            9/20/2010  5:57:11 PM
\par 
\par 
\par 278
\par 279        DATA PMEDS;
\par 280          MERGE FYPERS (IN=INFY)
\par 281                PMEDS  (IN=INRX)
\par 282          END=EOF;
\par 283          BY PERSID;
\par 284          IF INFY;
\par 285
\par 286          LABEL HASPMED = "1 if person has PMED event";
\par 287
\par 288          HASPMED=INRX;
\par 289
\par 290          IF NOT INRX
\par 291           THEN RXXP&YY.X=0;
\par 292
\par 293          C1 + (INFY AND NOT INRX);
\par 294          C2 + (INRX AND NOT INFY);
\par 295          C3 + (INRX AND INFY);
\par 296
\par 297          IF EOF THEN DO;
\par 298             PUT "IN FY CONSOLIDATED PUF ONLY: " C1;
\par \page 13                                                                    The SAS System                                       17:57 Monday, September 20, 2010
\par 
\par 299             PUT "IN PMED EVENT FILE ONLY: " C2;
\par 300             PUT "IN BOTH:                 " C3;
\par 301           END;
\par 302
\par 303           DROP C1 C2 C3;
\par 304        RUN;
\par 
\par IN FY CONSOLIDATED PUF ONLY: 13293
\par IN PMED EVENT FILE ONLY: 0
\par IN BOTH:                 287606
\par NOTE: There were 31262 observations read from the data set WORK.FYPERS.
\par NOTE: There were 287606 observations read from the data set WORK.PMEDS.
\par NOTE: The data set WORK.PMEDS has 300899 observations and 10 variables.
\par NOTE: DATA statement used (Total process time):
\par       real time           0:00.29
\par       user cpu time       0:00.21
\par       system cpu time     0:00.07
\par       Memory                            35492k
\par       OS Memory                         87460k
\par       Timestamp            9/20/2010  5:57:11 PM
\par 
\par 
\par 305
\par 306        *------------------------------------------------------------------------------------
\par 307        * Produce standard errors.
\par 308        *------------------------------------------------------------------------------------;
\par 309        PROC SORT DATA=PMEDS;
\par 310           BY VARSTR VARPSU;
\par 311        RUN;
\par 
\par NOTE: There were 300899 observations read from the data set WORK.PMEDS.
\par NOTE: The data set WORK.PMEDS has 300899 observations and 10 variables.
\par NOTE: PROCEDURE SORT used (Total process time):
\par       real time           0:00.34
\par       user cpu time       0:00.39
\par       system cpu time     0:00.15
\par       Memory                            80894k
\par       OS Memory                         136200k
\par       Timestamp            9/20/2010  5:57:12 PM
\par 
\par 
\par 312
\par 313        TITLE3;
\par 314        FOOTNOTE1;
\par 315        PROC DESCRIPT DATA=PMEDS NOPRINT;
\par 316          SUBPOPN HASPMED=1;
\par 317          WEIGHT PERWT&YY.F;
\par 318          NEST VARSTR VARPSU / MISSUNIT;
\par 319          VAR _ONE_ RXXP&YY.X RANKPERS;
\par 320          SUBGROUP RANK;
\par 321          LEVELS 26;
\par 322          SETENV LABWIDTH=40;
\par 323          OUTPUT NSUM WSUM TOTAL SETOTAL / FILENAME=SESTATS FILETYPE=SAS REPLACE;
\par \page 14                                                                    The SAS System                                       17:57 Monday, September 20, 2010
\par 
\par 324          RFORMAT RANK RANKFMT.;
\par 325        RUN;
\par 
\par 
\par ******************************************************************
\par SUDAAN Release 10.0.1 (SAS-Callable SUDAAN, x32 version)
\par Serial Number A0003992, for 5 user(s) is licensed to
\par Social and Scientific Systems, Inc. (Employee Owner).
\par It expires on January 31, 2011.
\par ******************************************************************
\par 
\par 
\par 
\par 
\par Opened SAS data file PMEDS for reading.
\par 
\par Opened SAS data file SESTATS for writing.
\par Note:
\par  81 records written to file SESTATS
\par 
\par 
\par NOTE: There were 300899 observations read from the data set WORK.PMEDS.
\par NOTE: The data set WORK.SESTATS has 81 observations and 9 variables.
\par NOTE: The PROCEDURE DESCRIPT printed page 7.
\par NOTE: PROCEDURE DESCRIPT used (Total process time):
\par       real time           0:01.82
\par       user cpu time       0:01.79
\par       system cpu time     0:00.00
\par       Memory                            1166k
\par       OS Memory                         56520k
\par       Timestamp            9/20/2010  5:57:13 PM
\par 
\par 
\par 326
\par 327        *----------------------------------------------------------------------------------
\par 328        * Reformat SUDAAN output for printing.
\par 329        *----------------------------------------------------------------------------------;
\par 330        DATA USE (RENAME=(TOTAL=TOT_USE SETOTAL=SE_USE))
\par 331             EXP (RENAME=(TOTAL=TOT_EXP SETOTAL=SE_EXP))
\par 332             PER (RENAME=(TOTAL=TOT_PER SETOTAL=SE_PER));
\par 333          SET SESTATS;
\par 334
\par 335          /* Move total line from top to bottom */
\par 336          IF RANK=0 THEN RANK=99;
\par 337
\par 338          IF VARIABLE=1 THEN OUTPUT USE; ELSE
\par 339          IF VARIABLE=2 THEN OUTPUT EXP; ELSE
\par 340          IF VARIABLE=3 THEN OUTPUT PER;
\par 341
\par 342          DROP PROCNUM TABLENO VARIABLE _C1;
\par 343        RUN;
\par 
\par NOTE: There were 81 observations read from the data set WORK.SESTATS.
\par \page 15                                                                    The SAS System                                       17:57 Monday, September 20, 2010
\par 
\par NOTE: The data set WORK.USE has 27 observations and 5 variables.
\par NOTE: The data set WORK.EXP has 27 observations and 5 variables.
\par NOTE: The data set WORK.PER has 27 observations and 5 variables.
\par NOTE: DATA statement used (Total process time):
\par       real time           0:00.00
\par       user cpu time       0:00.00
\par       system cpu time     0:00.00
\par       Memory                            253k
\par       OS Memory                         56260k
\par       Timestamp            9/20/2010  5:57:14 PM
\par 
\par 
\par 344
\par 345        PROC SORT DATA=USE; BY RANK; RUN;
\par 
\par NOTE: There were 27 observations read from the data set WORK.USE.
\par NOTE: The data set WORK.USE has 27 observations and 5 variables.
\par NOTE: PROCEDURE SORT used (Total process time):
\par       real time           0:00.00
\par       user cpu time       0:00.00
\par       system cpu time     0:00.00
\par       Memory                            90k
\par       OS Memory                         56260k
\par       Timestamp            9/20/2010  5:57:14 PM
\par 
\par 
\par 346        PROC SORT DATA=EXP; BY RANK; RUN;
\par 
\par NOTE: There were 27 observations read from the data set WORK.EXP.
\par NOTE: The data set WORK.EXP has 27 observations and 5 variables.
\par NOTE: PROCEDURE SORT used (Total process time):
\par       real time           0:00.01
\par       user cpu time       0:00.00
\par       system cpu time     0:00.01
\par       Memory                            90k
\par       OS Memory                         56260k
\par       Timestamp            9/20/2010  5:57:14 PM
\par 
\par 
\par 347        PROC SORT DATA=PER; BY RANK; RUN;
\par 
\par NOTE: There were 27 observations read from the data set WORK.PER.
\par NOTE: The data set WORK.PER has 27 observations and 5 variables.
\par NOTE: PROCEDURE SORT used (Total process time):
\par       real time           0:00.00
\par       user cpu time       0:00.00
\par       system cpu time     0:00.00
\par       Memory                            90k
\par       OS Memory                         56260k
\par       Timestamp            9/20/2010  5:57:14 PM
\par 
\par 
\par 348
\par \page 16                                                                    The SAS System                                       17:57 Monday, September 20, 2010
\par 
\par 349        DATA RXTAB.TOP25RX&YY._EXP;
\par 350          MERGE USE
\par 351                EXP
\par 352                PER;
\par 353          BY RANK;
\par 354          LABEL RANK    = "Drug Rank & Name"
\par 355                NSUM    = "Drug Mentions, Unweighted"
\par 356                TOT_USE = "Drug Mentions, Weighted"
\par 357                 SE_USE = "Drug Mentions SE"
\par 358                TOT_EXP = "Dollars Spent, Weighted"
\par 359                 SE_EXP = "Dollars Spent SE"
\par 360                TOT_PER = "Count of Persons, Weighted"
\par 361                 SE_PER = "Count of Persons SE";
\par 362        RUN;
\par 
\par NOTE: There were 27 observations read from the data set WORK.USE.
\par NOTE: There were 27 observations read from the data set WORK.EXP.
\par NOTE: There were 27 observations read from the data set WORK.PER.
\par NOTE: The data set RXTAB.TOP25RX08_EXP has 27 observations and 9 variables.
\par NOTE: DATA statement used (Total process time):
\par       real time           0:00.01
\par       user cpu time       0:00.00
\par       system cpu time     0:00.01
\par       Memory                            311k
\par       OS Memory                         56260k
\par       Timestamp            9/20/2010  5:57:14 PM
\par 
\par 
\par 363
\par 364        PROC CONTENTS DATA=RXTAB.TOP25RX&YY._EXP;
\par 365          TITLE3 "Contents of TOP25RX&YY._EXP.SAS7BDAT";
\par 366          TITLE5 "Dataset for Table Top Rx Ranked by Expenditures";
\par 367          FOOTNOTE1 "c:\\AHRQ3\\F_DSO\\FD001NKK\\DATA\\TABLES\\TOP25RX&YY._EXP.SAS7BDAT";
\par 368        RUN;
\par 
\par NOTE: PROCEDURE CONTENTS used (Total process time):
\par       real time           0:00.00
\par       user cpu time       0:00.00
\par       system cpu time     0:00.00
\par       Memory                            180k
\par       OS Memory                         56260k
\par       Timestamp            9/20/2010  5:57:14 PM
\par 
\par NOTE: The PROCEDURE CONTENTS printed page 8.
\par 
\par 369
\par 370        PROC PRINT DATA=RXTAB.TOP25RX&YY._EXP NOOBS SPLIT="*";
\par 371          ID RANK;
\par 372          VAR NSUM
\par 373              TOT_USE SE_USE
\par 374              TOT_EXP SE_EXP
\par 375              TOT_PER SE_PER;
\par 376           FORMAT RANK RANKFMT.;
\par \page 17                                                                    The SAS System                                       17:57 Monday, September 20, 2010
\par 
\par 377           FORMAT NSUM COMMA8.;
\par 378           FORMAT TOT_USE TOT_EXP TOT_PER COMMA20.;
\par 379           FORMAT  SE_USE  SE_EXP  SE_PER COMMA20.2;
\par 380           LABEL RANK    = "Drug*Rank &*Name"
\par 381                 NSUM    = "Drug*Mentions*Unweighted"
\par 382                 TOT_USE = "Drug*Mentions*Weighted"
\par 383                  SE_USE = "Drug*Mentions*SE"
\par 384                 TOT_EXP = "Dollars*Spent*Weighted"
\par 385                  SE_EXP = "Dollars*Spent*SE"
\par 386                 TOT_PER = "Count of*Persons*Weighted"
\par 387                  SE_PER = "Count of*Persons*SE";
\par 388          TITLE3 "Utilization and Expenditures for the Top 25 Prescribed Medicines";
\par 389          TITLE5 "Ranked by Weighted Expenditures";
\par 390          TITLE7 "SUDAAN Output";
\par 391        RUN;
\par 
\par NOTE: There were 27 observations read from the data set RXTAB.TOP25RX08_EXP.
\par NOTE: The PROCEDURE PRINT printed page 9.
\par NOTE: PROCEDURE PRINT used (Total process time):
\par       real time           0:00.00
\par       user cpu time       0:00.00
\par       system cpu time     0:00.00
\par       Memory                            159k
\par       OS Memory                         56260k
\par       Timestamp            9/20/2010  5:57:14 PM
\par 
\par 
\par 392
\par 393        *----------------------------------------------------------------------------------------
\par 394        * Compute z-scores for #1 v.s #2,#3,#4, etc. then #2 v.s #3,#4, etc. for top 25.
\par 395        *----------------------------------------------------------------------------------------;
\par 396        FOOTNOTE1;
\par 397        PROC SORT DATA=RXTAB.TOP25RX&YY._EXP (KEEP=RANK TOT_EXP SE_EXP WHERE=(1 LE RANK LE 25))
\par 398                   OUT=SETABLE;
\par 399          BY RANK;
\par 400        RUN;
\par 
\par NOTE: There were 25 observations read from the data set RXTAB.TOP25RX08_EXP.
\par       WHERE (RANK>=1 and RANK<=25);
\par NOTE: The data set WORK.SETABLE has 25 observations and 3 variables.
\par NOTE: PROCEDURE SORT used (Total process time):
\par       real time           0:00.01
\par       user cpu time       0:00.00
\par       system cpu time     0:00.01
\par       Memory                            428k
\par       OS Memory                         56544k
\par       Timestamp            9/20/2010  5:57:14 PM
\par 
\par 
\par 401
\par 402        PROC PRINT DATA=SETABLE;
\par 403          FORMAT RANK RANKFMT.;
\par 404          FORMAT TOT_EXP SE_EXP COMMA20.2;
\par \page 18                                                                    The SAS System                                       17:57 Monday, September 20, 2010
\par 
\par 405          TITLE3 "QC testing for Z-Score computation";
\par 406          TITLE5 "before re-arranging variables";
\par 407        RUN;
\par 
\par NOTE: There were 25 observations read from the data set WORK.SETABLE.
\par NOTE: The PROCEDURE PRINT printed page 10.
\par NOTE: PROCEDURE PRINT used (Total process time):
\par       real time           0:00.00
\par       user cpu time       0:00.00
\par       system cpu time     0:00.00
\par       Memory                            105k
\par       OS Memory                         56260k
\par       Timestamp            9/20/2010  5:57:14 PM
\par 
\par 
\par 408
\par 409        /* Put all the observations into a single observation using arrays */
\par 410        DATA SIGSTAT (DROP=RANK TOT_EXP SE_EXP);
\par 411          SET SETABLE END=EOF;
\par 412          BY RANK;
\par 413
\par 414          RETAIN RANK1-RANK25
\par 415                 STAT1-STAT25
\par 416                 SE1-SE25;
\par 417
\par 418          ARRAY RNK(25)  RANK1-RANK25;
\par 419          ARRAY STAT(25) STAT1-STAT25;
\par 420          ARRAY SE(25)   SE1-SE25;
\par 421
\par 422          IF _N_=1 THEN NSTAT=0;
\par 423
\par 424          NSTAT+1;
\par 425          RNK(NSTAT)=NSTAT;
\par 426          STAT(NSTAT)=TOT_EXP;
\par 427          SE(NSTAT)=SE_EXP;
\par 428
\par 429          IF EOF THEN OUTPUT;
\par 430        RUN;
\par 
\par NOTE: There were 25 observations read from the data set WORK.SETABLE.
\par NOTE: The data set WORK.SIGSTAT has 1 observations and 76 variables.
\par NOTE: DATA statement used (Total process time):
\par       real time           0:00.01
\par       user cpu time       0:00.01
\par       system cpu time     0:00.00
\par       Memory                            318k
\par       OS Memory                         56260k
\par       Timestamp            9/20/2010  5:57:14 PM
\par 
\par 
\par 431
\par 432        PROC PRINT DATA=SIGSTAT;
\par 433          TITLE3 "QC testing for Z-Score computation";
\par \page 19                                                                    The SAS System                                       17:57 Monday, September 20, 2010
\par 
\par 434          TITLE5 "after re-arranging variables";
\par 435        RUN;
\par 
\par NOTE: There were 1 observations read from the data set WORK.SIGSTAT.
\par NOTE: The PROCEDURE PRINT printed page 11.
\par NOTE: PROCEDURE PRINT used (Total process time):
\par       real time           0:00.00
\par       user cpu time       0:00.00
\par       system cpu time     0:00.00
\par       Memory                            227k
\par       OS Memory                         56260k
\par       Timestamp            9/20/2010  5:57:14 PM
\par 
\par 
\par 436
\par 437        /* Compute Z-Scores */
\par 438        DATA ZSCORE (KEEP=DRUG1 DRUG2
\par 439                          TOTAL1 TOTAL2
\par 440                          SE_EXP1 SE_EXP2
\par 441                          STATDIFF SESQRT ZSTAT PVALUE);
\par 442          SET SIGSTAT;
\par 443
\par 444          ARRAY RNK(25)   RANK1-RANK25;
\par 445          ARRAY CSTAT(25) STAT1-STAT25;
\par 446          ARRAY CSE(25)   SE1-SE25;
\par 447
\par 448          DO M=1 TO NSTAT-1;
\par 449             DO J=1 TO (NSTAT-M);
\par 450                DRUG1=RNK(M);
\par 451                TOTAL1=CSTAT(M);
\par 452                SE_EXP1=CSE(M);
\par 453
\par 454                DRUG2=RNK(M+J);
\par 455                TOTAL2=CSTAT(M+J);
\par 456                SE_EXP2=CSE(M+J);
\par 457
\par 458                STATDIFF=TOTAL1-TOTAL2;
\par 459                SESQRT=SQRT((SE_EXP1)**2 + (SE_EXP2)**2);
\par 460                ZSTAT=ABS(STATDIFF / SESQRT);
\par 461                PVALUE=PDF("NORMAL",ZSTAT);
\par 462
\par 463                OUTPUT;
\par 464             END;
\par 465          END;
\par 466
\par 467        RUN;
\par 
\par NOTE: There were 1 observations read from the data set WORK.SIGSTAT.
\par NOTE: The data set WORK.ZSCORE has 300 observations and 10 variables.
\par NOTE: DATA statement used (Total process time):
\par       real time           0:00.03
\par       user cpu time       0:00.00
\par       system cpu time     0:00.00
\par \page 20                                                                    The SAS System                                       17:57 Monday, September 20, 2010
\par 
\par       Memory                            316k
\par       OS Memory                         56260k
\par       Timestamp            9/20/2010  5:57:14 PM
\par 
\par 
\par 468
\par 469        PROC PRINT DATA=ZSCORE NOOBS SPLIT="*";
\par 470          BY DRUG1;
\par 471          ID DRUG1;
\par 472          VAR DRUG2 TOTAL1 TOTAL2 SE_EXP1 SE_EXP2 STATDIFF SESQRT ZSTAT PVALUE;
\par 473          FORMAT DRUG1 DRUG2 RANKFMT.;
\par 474          FORMAT TOTAL1 TOTAL2 STATDIFF COMMA20.2;
\par 475          FORMAT SE_EXP1 SE_EXP2 SESQRT COMMA16.2;
\par 476          FORMAT ZSTAT 6.3;
\par 477          FORMAT PVALUE PVALUE6.3;
\par 478          LABEL DRUG1    = "Drug #1"
\par 479                DRUG2    = "Drug #2"
\par 480                TOTAL1   = "Weighted*Expenditures* for Drug #1"
\par 481                TOTAL2   = "Weighted*Expenditures* for Drug #2"
\par 482                SE_EXP1  = "SE of Weighted*Expenditures* Drug #1"
\par 483                SE_EXP2  = "SE of Weighted*Expenditures* Drug #2"
\par 484                STATDIFF = "TOTAL1-TOTAL2"
\par 485                SESQRT   = "SESQRT"
\par 486                ZSTAT    = "Z-SCORE"
\par 487                PVALUE   = "P-VALUE";
\par 488          TITLE3 "Z Scores to Compare Top 25 Drugs when Ranked by Weighted Expenditures";
\par 489        RUN;
\par 
\par NOTE: There were 300 observations read from the data set WORK.ZSCORE.
\par NOTE: The PROCEDURE PRINT printed pages 12-32.
\par NOTE: PROCEDURE PRINT used (Total process time):
\par       real time           0:00.03
\par       user cpu time       0:00.00
\par       system cpu time     0:00.01
\par       Memory                            267k
\par       OS Memory                         56260k
\par       Timestamp            9/20/2010  5:57:14 PM
\par 
\par 
\par 490
\par 491
\par 492
\par 493        %JOBEND;
\par |~~~~~~~~~~~~~~~~~~~~~~~~|
\par | FINISH DATE : 09/20/10 |
\par | FINISH TIME : 17:57:14 |
\par | JOB DURATION:  0:00:07 |
\par |~~~~~~~~~~~~~~~~~~~~~~~~|
\par NOTE: SAS Institute Inc., SAS Campus Drive, Cary, NC USA 27513-2414
\par NOTE: The SAS System used:
\par       real time           0:08.21
\par       user cpu time       0:05.71
\par       system cpu time     0:01.51
\par \page 21                                                                    The SAS System                                       17:57 Monday, September 20, 2010
\par 
\par       Memory                            123985k
\par       OS Memory                         136200k
\par       Timestamp            9/20/2010  5:57:14 PM
\par 
\par \page                                                     Task AH3.FD001: 2008 Prescribed Medicines Event PUF                17:57 Monday, September 20, 2010   1
\par 
\par                                                            Verification of RANK by medicine name
\par 
\par                                                             RANK based on weighted expenditures
\par 
\par                                                                                          Cumulative    Cumulative
\par                                          RANK    PARTMED_WEB    Frequency     Percent     Frequency      Percent
\par                                          ------------------------------------------------------------------------
\par                                             1    LIPITOR            5536        1.92          5536         1.92
\par                                             2    NEXIUM             2415        0.84          7951         2.76
\par                                             3    SIMVASTATIN        6675        2.32         14626         5.09
\par                                             4    ADVAIR             2065        0.72         16691         5.80
\par                                             5    PLAVIX             2345        0.82         19036         6.62
\par                                             6    ACTOS              1619        0.56         20655         7.18
\par                                             7    DIOVAN             3094        1.08         23749         8.26
\par                                             8    PREVACID           1503        0.52         25252         8.78
\par                                             9    SINGULAIR          2355        0.82         27607         9.60
\par                                            10    LANTUS             1498        0.52         29105        10.12
\par                                            11    CRESTOR            1935        0.67         31040        10.79
\par                                            12    VYTORIN            1617        0.56         32657        11.35
\par                                            13    EFFEXOR            1222        0.42         33879        11.78
\par                                            14    LAMICTAL            476        0.17         34355        11.95
\par                                            15    ABILIFY             548        0.19         34903        12.14
\par                                            16    LEXAPRO            1887        0.66         36790        12.79
\par                                            17    CYMBALTA           1126        0.39         37916        13.18
\par                                            18    PROVIGIL            250        0.09         38166        13.27
\par                                            19    SEROQUEL            882        0.31         39048        13.58
\par                                            20    CELEBREX           1007        0.35         40055        13.93
\par                                            21    TRICOR             1097        0.38         41152        14.31
\par                                            22    FLUOXETINE         1762        0.61         42914        14.92
\par                                            23    ZETIA               884        0.31         43798        15.23
\par                                            24    TOPAMAX             619        0.22         44417        15.44
\par                                            25    FLOMAX             1020        0.35         45437        15.80
\par                                            26    All Others       242169       84.20        287606       100.00
\par 
\par 
\par 
\par 
\par 
\par 
\par 
\par 
\par 
\par 
\par 
\par 
\par 
\par 
\par 
\par 
\par 
\par 
\par                                                   Source file: AHRQ3\\F_DSO\\FD001NKK\\DATA\\RX08V06.SAS7BDAT
\par                                                                        PERWT08F > 0
\par \page                                                     Task AH3.FD001: 2008 Prescribed Medicines Event PUF                17:57 Monday, September 20, 2010   2
\par 
\par                                                     Verification of creating formats for variable RANK
\par 
\par                                        WORK.FMTDRUGS: Input Control Dataset used to create permanent format for RANK
\par 
\par                                                      Obs    FMTNAME    START    LABEL            TYPE
\par 
\par                                                        1    RANKFMT      1      1 LIPITOR         N
\par                                                        2    RANKFMT      2      2 NEXIUM          N
\par                                                        3    RANKFMT      3      3 SIMVASTATIN     N
\par                                                        4    RANKFMT      4      4 ADVAIR          N
\par                                                        5    RANKFMT      5      5 PLAVIX          N
\par                                                        6    RANKFMT      6      6 ACTOS           N
\par                                                        7    RANKFMT      7      7 DIOVAN          N
\par                                                        8    RANKFMT      8      8 PREVACID        N
\par                                                        9    RANKFMT      9      9 SINGULAIR       N
\par                                                       10    RANKFMT     10      10 LANTUS         N
\par                                                       11    RANKFMT     11      11 CRESTOR        N
\par                                                       12    RANKFMT     12      12 VYTORIN        N
\par                                                       13    RANKFMT     13      13 EFFEXOR        N
\par                                                       14    RANKFMT     14      14 LAMICTAL       N
\par                                                       15    RANKFMT     15      15 ABILIFY        N
\par                                                       16    RANKFMT     16      16 LEXAPRO        N
\par                                                       17    RANKFMT     17      17 CYMBALTA       N
\par                                                       18    RANKFMT     18      18 PROVIGIL       N
\par                                                       19    RANKFMT     19      19 SEROQUEL       N
\par                                                       20    RANKFMT     20      20 CELEBREX       N
\par                                                       21    RANKFMT     21      21 TRICOR         N
\par                                                       22    RANKFMT     22      22 FLUOXETINE     N
\par                                                       23    RANKFMT     23      23 ZETIA          N
\par                                                       24    RANKFMT     24      24 TOPAMAX        N
\par                                                       25    RANKFMT     25      25 FLOMAX         N
\par                                                       26    RANKFMT     26      26 All Others     N
\par                                                       27    RANKFMT     99      TOTAL             N
\par \page                                                     Task AH3.FD001: 2008 Prescribed Medicines Event PUF                17:57 Monday, September 20, 2010   3
\par 
\par                                                        Contents of permanent format library for RANK
\par 
\par                                        ----------------------------------------------------------------------------
\par                                        |       FORMAT NAME: RANKFMT  LENGTH:   13   NUMBER OF VALUES:   27        |
\par                                        |   MIN LENGTH:   1  MAX LENGTH:  40  DEFAULT LENGTH  13  FUZZ: STD        |
\par                                        |--------------------------------------------------------------------------|
\par                                        |START           |END             |LABEL  (VER. V7|V8   20SEP2010:17:57:10)|
\par                                        |----------------+----------------+----------------------------------------|
\par                                        |               1|               1|1 LIPITOR                               |
\par                                        |               2|               2|2 NEXIUM                                |
\par                                        |               3|               3|3 SIMVASTATIN                           |
\par                                        |               4|               4|4 ADVAIR                                |
\par                                        |               5|               5|5 PLAVIX                                |
\par                                        |               6|               6|6 ACTOS                                 |
\par                                        |               7|               7|7 DIOVAN                                |
\par                                        |               8|               8|8 PREVACID                              |
\par                                        |               9|               9|9 SINGULAIR                             |
\par                                        |              10|              10|10 LANTUS                               |
\par                                        |              11|              11|11 CRESTOR                              |
\par                                        |              12|              12|12 VYTORIN                              |
\par                                        |              13|              13|13 EFFEXOR                              |
\par                                        |              14|              14|14 LAMICTAL                             |
\par                                        |              15|              15|15 ABILIFY                              |
\par                                        |              16|              16|16 LEXAPRO                              |
\par                                        |              17|              17|17 CYMBALTA                             |
\par                                        |              18|              18|18 PROVIGIL                             |
\par                                        |              19|              19|19 SEROQUEL                             |
\par                                        |              20|              20|20 CELEBREX                             |
\par                                        |              21|              21|21 TRICOR                               |
\par                                        |              22|              22|22 FLUOXETINE                           |
\par                                        |              23|              23|23 ZETIA                                |
\par                                        |              24|              24|24 TOPAMAX                              |
\par                                        |              25|              25|25 FLOMAX                               |
\par                                        |              26|              26|26 All Others                           |
\par                                        |              99|              99|TOTAL                                   |
\par                                        ----------------------------------------------------------------------------
\par 
\par 
\par 
\par 
\par 
\par 
\par 
\par 
\par 
\par 
\par 
\par 
\par 
\par 
\par 
\par 
\par                                                       c:\\AHRQ3\\F_DSO\\FD001NKK\\DATA\\FMTLIB\\RX08_EXPFMT
\par \page                                                     Task AH3.FD001: 2008 Prescribed Medicines Event PUF                17:57 Monday, September 20, 2010   4
\par 
\par                                                           Unweighted formatted frequency of RANK
\par 
\par                                                             RANK based on weighted expenditures
\par 
\par                                                                                       Cumulative    Cumulative
\par                                                      RANK    Frequency     Percent     Frequency      Percent
\par                                             ------------------------------------------------------------------
\par                                             1 LIPITOR            5536        1.92          5536         1.92
\par                                             2 NEXIUM             2415        0.84          7951         2.76
\par                                             3 SIMVASTATIN        6675        2.32         14626         5.09
\par                                             4 ADVAIR             2065        0.72         16691         5.80
\par                                             5 PLAVIX             2345        0.82         19036         6.62
\par                                             6 ACTOS              1619        0.56         20655         7.18
\par                                             7 DIOVAN             3094        1.08         23749         8.26
\par                                             8 PREVACID           1503        0.52         25252         8.78
\par                                             9 SINGULAIR          2355        0.82         27607         9.60
\par                                             10 LANTUS            1498        0.52         29105        10.12
\par                                             11 CRESTOR           1935        0.67         31040        10.79
\par                                             12 VYTORIN           1617        0.56         32657        11.35
\par                                             13 EFFEXOR           1222        0.42         33879        11.78
\par                                             14 LAMICTAL           476        0.17         34355        11.95
\par                                             15 ABILIFY            548        0.19         34903        12.14
\par                                             16 LEXAPRO           1887        0.66         36790        12.79
\par                                             17 CYMBALTA          1126        0.39         37916        13.18
\par                                             18 PROVIGIL           250        0.09         38166        13.27
\par                                             19 SEROQUEL           882        0.31         39048        13.58
\par                                             20 CELEBREX          1007        0.35         40055        13.93
\par                                             21 TRICOR            1097        0.38         41152        14.31
\par                                             22 FLUOXETINE        1762        0.61         42914        14.92
\par                                             23 ZETIA              884        0.31         43798        15.23
\par                                             24 TOPAMAX            619        0.22         44417        15.44
\par                                             25 FLOMAX            1020        0.35         45437        15.80
\par                                             26 All Others      242169       84.20        287606       100.00
\par \page                                                     Task AH3.FD001: 2008 Prescribed Medicines Event PUF                17:57 Monday, September 20, 2010   5
\par 
\par                                                            Weighted formatted frequency of RANK
\par 
\par                                                             RANK based on weighted expenditures
\par 
\par                                                                                       Cumulative    Cumulative
\par                                                      RANK    Frequency     Percent     Frequency      Percent
\par                                             ------------------------------------------------------------------
\par                                             1 LIPITOR        63579262        2.02      63579262         2.02
\par                                             2 NEXIUM         26260192        0.83      89839454         2.85
\par                                             3 SIMVASTATIN    74200966        2.36      1.6404E8         5.21
\par                                             4 ADVAIR         23504834        0.75      1.8755E8         5.95
\par                                             5 PLAVIX         27220555        0.86      2.1477E8         6.82
\par                                             6 ACTOS          15206469        0.48      2.2997E8         7.30
\par                                             7 DIOVAN         33509406        1.06      2.6348E8         8.36
\par                                             8 PREVACID       16411714        0.52      2.7989E8         8.89
\par                                             9 SINGULAIR      23917046        0.76      3.0381E8         9.65
\par                                             10 LANTUS        16085086        0.51       3.199E8        10.16
\par                                             11 CRESTOR       22458333        0.71      3.4235E8        10.87
\par                                             12 VYTORIN       18718988        0.59      3.6107E8        11.46
\par                                             13 EFFEXOR       15307247        0.49      3.7638E8        11.95
\par                                             14 LAMICTAL       7023081        0.22       3.834E8        12.17
\par                                             15 ABILIFY        5624615        0.18      3.8903E8        12.35
\par                                             16 LEXAPRO       22952979        0.73      4.1198E8        13.08
\par                                             17 CYMBALTA      13996983        0.44      4.2598E8        13.52
\par                                             18 PROVIGIL       4010752        0.13      4.2999E8        13.65
\par                                             19 SEROQUEL       8465971        0.27      4.3845E8        13.92
\par                                             20 CELEBREX      10925332        0.35      4.4938E8        14.27
\par                                             21 TRICOR        12828874        0.41      4.6221E8        14.67
\par                                             22 FLUOXETINE    22702242        0.72      4.8491E8        15.39
\par                                             23 ZETIA         11599056        0.37      4.9651E8        15.76
\par                                             24 TOPAMAX        7267757        0.23      5.0378E8        15.99
\par                                             25 FLOMAX        13126927        0.42       5.169E8        16.41
\par                                             26 All Others     2.633E9       83.59      3.1499E9       100.00
\par \page                                                     Task AH3.FD001: 2008 Prescribed Medicines Event PUF                17:57 Monday, September 20, 2010   6
\par 
\par                                              Utilization and Expenditures for the Top 25 Prescribed Medicines
\par 
\par                                                               Ranked by Weighted Expenditures
\par 
\par                                                                         SAS Output
\par 
\par                               Drug                Drug                       Drug                 Dollars           Count of
\par                               Rank &            Mentions                 Mentions                   Spent            Persons
\par                               Name             Unweighted                Weighted                Weighted           Weighted
\par 
\par                               1 LIPITOR            5,536               63,579,262           9,637,282,935         11,270,375
\par                               2 NEXIUM             2,415               26,260,192           7,540,195,953          5,328,046
\par                               3 SIMVASTATIN        6,675               74,200,966           5,270,883,955         13,646,672
\par                               4 ADVAIR             2,065               23,504,834           5,263,057,480          5,070,844
\par                               5 PLAVIX             2,345               27,220,555           4,834,909,168          4,418,278
\par                               6 ACTOS              1,619               15,206,469           3,896,299,733          2,803,991
\par                               7 DIOVAN             3,094               33,509,406           3,486,593,510          5,157,286
\par                               8 PREVACID           1,503               16,411,714           3,459,262,683          3,494,035
\par                               9 SINGULAIR          2,355               23,917,046           3,258,483,207          5,560,086
\par                               10 LANTUS            1,498               16,085,086           3,026,637,829          2,187,634
\par                               11 CRESTOR           1,935               22,458,333           2,930,929,524          3,970,954
\par                               12 VYTORIN           1,617               18,718,988           2,550,182,268          3,583,546
\par                               13 EFFEXOR           1,222               15,307,247           2,498,042,880          2,644,377
\par                               14 LAMICTAL            476                7,023,081           2,447,915,296          1,294,302
\par                               15 ABILIFY             548                5,624,615           2,428,735,424          1,090,179
\par                               16 LEXAPRO           1,887               22,952,979           2,421,543,724          4,232,497
\par                               17 CYMBALTA          1,126               13,996,983           2,360,616,946          2,445,397
\par                               18 PROVIGIL            250                4,010,752           2,027,008,379            579,173
\par                               19 SEROQUEL            882                8,465,971           2,000,885,194          1,466,684
\par                               20 CELEBREX          1,007               10,925,332           1,997,616,682          2,825,360
\par                               21 TRICOR            1,097               12,828,874           1,870,260,630          2,421,615
\par                               22 FLUOXETINE        1,762               22,702,242           1,869,188,565          4,069,985
\par                               23 ZETIA               884               11,599,056           1,854,446,394          2,558,704
\par                               24 TOPAMAX             619                7,267,757           1,735,207,027          1,309,138
\par                               25 FLOMAX            1,020               13,126,927           1,694,233,600          2,704,715
\par                               26 All Others      242,169            2,633,010,296         165,074,064,159        185,272,478
\par                               TOTAL              287,606            3,149,914,963         247,434,483,143        281,406,347
\par 
\par 
\par 
\par 
\par 
\par 
\par 
\par 
\par 
\par 
\par 
\par 
\par 
\par 
\par                                                   Source file: AHRQ3\\F_DSO\\FD001NKK\\DATA\\RX08V06.SAS7BDAT
\par                                                                        PERWT08F > 0
\par \page                                                     Task AH3.FD001: 2008 Prescribed Medicines Event PUF                17:57 Monday, September 20, 2010   7
\par 
\par 
\par 
\par 
\par                                   S U D A A N
\par             Software for the Statistical Analysis of Correlated Data
\par           Copyright      Research Triangle Institute      October 2009
\par                                 Release 10.0.1
\par 
\par 
\par DESIGN SUMMARY: Variances will be computed using the Taylor Linearization Method, Assuming a With Replacement (WR) Design
\par     Sample Weight: PERWT08F
\par     Stratification Variables(s): VARSTR
\par     Primary Sampling Unit: VARPSU
\par 
\par 
\par Number of observations read    : 300899    Weighted count :3264656788
\par Observations in subpopulation  : 287606    Weighted count :3149914963
\par Denominator degrees of freedom :    205
\par 
\par \page                                                     Task AH3.FD001: 2008 Prescribed Medicines Event PUF                17:57 Monday, September 20, 2010   8
\par 
\par                                                             Contents of TOP25RX08_EXP.SAS7BDAT
\par 
\par                                                       Dataset for Table Top Rx Ranked by Expenditures
\par 
\par                                   Data Set Name        RXTAB.TOP25RX08_EXP                       Observations          27
\par                                   Member Type          DATA                                      Variables             9
\par                                   Engine               V9                                        Indexes               0
\par                                   Created              Monday, September 20, 2010 05:57:14 PM    Observation Length    72
\par                                   Last Modified        Monday, September 20, 2010 05:57:14 PM    Deleted Observations  0
\par                                   Protection                                                     Compressed            NO
\par                                   Data Set Type                                                  Sorted                NO
\par                                   Label
\par                                   Data Representation  WINDOWS_32
\par                                   Encoding             wlatin1  Western (Windows)
\par 
\par 
\par                                                             Engine/Host Dependent Information
\par 
\par                                   Data Set Page Size          8192
\par                                   Number of Data Set Pages    1
\par                                   First Data Page             1
\par                                   Max Obs per Page            113
\par                                   Obs in First Data Page      27
\par                                   Number of Data Set Repairs  0
\par                                   Filename                    c:\\AHRQ3\\F_DSO\\FD001NKK\\DATA\\TABLES\\top25rx08_exp.sas7bdat
\par                                   Release Created             9.0201M0
\par                                   Host Created                XP_PRO
\par 
\par 
\par                                                         Alphabetic List of Variables and Attributes
\par 
\par                                           #    Variable    Type    Len    Format      Label
\par 
\par                                           2    NSUM        Num       8    8.          Drug Mentions, Unweighted
\par                                           1    RANK        Num       8    RANKFMT.    Drug Rank & Name
\par                                           7    SE_EXP      Num       8    12.2        Dollars Spent SE
\par                                           9    SE_PER      Num       8    12.2        Count of Persons SE
\par                                           5    SE_USE      Num       8    12.2        Drug Mentions SE
\par                                           6    TOT_EXP     Num       8    12.2        Dollars Spent, Weighted
\par                                           8    TOT_PER     Num       8    12.2        Count of Persons, Weighted
\par                                           4    TOT_USE     Num       8    12.2        Drug Mentions, Weighted
\par                                           3    WSUM        Num       8    10.2        Weighted Size
\par 
\par 
\par 
\par 
\par 
\par 
\par 
\par 
\par 
\par 
\par                                                 c:\\AHRQ3\\F_DSO\\FD001NKK\\DATA\\TABLES\\TOP25RX08_EXP.SAS7BDAT
\par \page                                                     Task AH3.FD001: 2008 Prescribed Medicines Event PUF                17:57 Monday, September 20, 2010   9
\par 
\par                                              Utilization and Expenditures for the Top 25 Prescribed Medicines
\par 
\par                                                               Ranked by Weighted Expenditures
\par 
\par                                                                        SUDAAN Output
\par 
\par   Drug             Drug                    Drug                 Drug              Dollars              Dollars             Count of             Count of
\par   Rank &         Mentions              Mentions             Mentions                Spent                Spent              Persons              Persons
\par   Name          Unweighted             Weighted                   SE             Weighted                   SE             Weighted                   SE
\par 
\par   1 LIPITOR         5,536            63,579,262         3,455,237.59        9,637,282,935       549,978,336.73           11,270,375           563,879.02
\par   2 NEXIUM          2,415            26,260,192         1,820,672.93        7,540,195,953       627,466,327.91            5,328,046           330,592.25
\par   3 SIMVASTATIN     6,675            74,200,966         4,131,807.01        5,270,883,955       408,912,973.54           13,646,672           670,167.02
\par   4 ADVAIR          2,065            23,504,834         1,712,436.16        5,263,057,480       423,242,609.74            5,070,844           289,637.15
\par   5 PLAVIX          2,345            27,220,555         2,305,157.24        4,834,909,168       411,850,461.96            4,418,278           305,466.93
\par   6 ACTOS           1,619            15,206,469         1,359,222.91        3,896,299,733       399,168,724.06            2,803,991           223,671.52
\par   7 DIOVAN          3,094            33,509,406         2,523,127.86        3,486,593,510       293,847,051.63            5,157,286           347,427.68
\par   8 PREVACID        1,503            16,411,714         1,675,080.11        3,459,262,683       363,913,378.63            3,494,035           289,552.12
\par   9 SINGULAIR       2,355            23,917,046         1,950,148.01        3,258,483,207       278,222,841.31            5,560,086           347,931.63
\par   10 LANTUS         1,498            16,085,086         1,902,943.94        3,026,637,829       395,140,493.47            2,187,634           193,194.36
\par   11 CRESTOR        1,935            22,458,333         1,864,341.02        2,930,929,524       263,473,713.63            3,970,954           311,848.61
\par   12 VYTORIN        1,617            18,718,988         1,549,286.71        2,550,182,268       235,377,992.53            3,583,546           270,895.19
\par   13 EFFEXOR        1,222            15,307,247         1,408,341.71        2,498,042,880       244,675,502.82            2,644,377           233,637.49
\par   14 LAMICTAL         476             7,023,081         1,079,844.39        2,447,915,296       564,004,308.64            1,294,302           181,306.30
\par   15 ABILIFY          548             5,624,615           778,081.86        2,428,735,424       354,462,837.64            1,090,179           148,529.44
\par   16 LEXAPRO        1,887            22,952,979         2,020,715.52        2,421,543,724       223,260,928.94            4,232,497           289,016.20
\par   17 CYMBALTA       1,126            13,996,983         1,594,084.72        2,360,616,946       270,508,386.83            2,445,397           222,224.11
\par   18 PROVIGIL         250             4,010,752           802,216.12        2,027,008,379       490,477,962.63              579,173           102,268.67
\par   19 SEROQUEL         882             8,465,971         1,123,632.76        2,000,885,194       366,744,538.18            1,466,684           162,857.70
\par   20 CELEBREX       1,007            10,925,332         1,034,784.84        1,997,616,682       200,550,827.23            2,825,360           219,345.27
\par   21 TRICOR         1,097            12,828,874         1,364,070.78        1,870,260,630       236,919,562.72            2,421,615           214,815.87
\par   22 FLUOXETINE     1,762            22,702,242         2,082,109.65        1,869,188,565       234,874,905.58            4,069,985           301,175.30
\par   23 ZETIA            884            11,599,056         1,147,855.25        1,854,446,394       200,993,518.88            2,558,704           229,683.68
\par   24 TOPAMAX          619             7,267,757         1,049,432.30        1,735,207,027       281,155,457.26            1,309,138           174,019.75
\par   25 FLOMAX         1,020            13,126,927         1,475,016.12        1,694,233,600       198,289,566.91            2,704,715           249,385.60
\par   26 All Others   242,169         2,633,010,296        70,942,469.74      165,074,064,159     5,243,879,862.77          185,272,478         4,107,160.11
\par   TOTAL           287,606         3,149,914,963        85,732,655.29      247,434,483,143     7,432,088,023.09          281,406,347         6,596,019.56
\par 
\par 
\par 
\par 
\par 
\par 
\par 
\par 
\par 
\par 
\par 
\par 
\par 
\par 
\par 
\par                                                 c:\\AHRQ3\\F_DSO\\FD001NKK\\DATA\\TABLES\\TOP25RX08_EXP.SAS7BDAT
\par \page                                                     Task AH3.FD001: 2008 Prescribed Medicines Event PUF                17:57 Monday, September 20, 2010  10
\par 
\par                                                             QC testing for Z-Score computation
\par 
\par                                                                before re-arranging variables
\par 
\par                                            Obs    RANK                          TOT_EXP                  SE_EXP
\par 
\par                                              1    1 LIPITOR            9,637,282,934.88          549,978,336.73
\par                                              2    2 NEXIUM             7,540,195,953.25          627,466,327.91
\par                                              3    3 SIMVASTATIN        5,270,883,954.77          408,912,973.54
\par                                              4    4 ADVAIR             5,263,057,480.25          423,242,609.74
\par                                              5    5 PLAVIX             4,834,909,167.69          411,850,461.96
\par                                              6    6 ACTOS              3,896,299,732.58          399,168,724.06
\par                                              7    7 DIOVAN             3,486,593,509.85          293,847,051.63
\par                                              8    8 PREVACID           3,459,262,683.30          363,913,378.63
\par                                              9    9 SINGULAIR          3,258,483,206.67          278,222,841.31
\par                                             10    10 LANTUS            3,026,637,828.60          395,140,493.47
\par                                             11    11 CRESTOR           2,930,929,524.25          263,473,713.63
\par                                             12    12 VYTORIN           2,550,182,267.65          235,377,992.53
\par                                             13    13 EFFEXOR           2,498,042,879.88          244,675,502.82
\par                                             14    14 LAMICTAL          2,447,915,296.19          564,004,308.64
\par                                             15    15 ABILIFY           2,428,735,423.99          354,462,837.64
\par                                             16    16 LEXAPRO           2,421,543,723.92          223,260,928.94
\par                                             17    17 CYMBALTA          2,360,616,946.47          270,508,386.83
\par                                             18    18 PROVIGIL          2,027,008,378.60          490,477,962.63
\par                                             19    19 SEROQUEL          2,000,885,193.93          366,744,538.18
\par                                             20    20 CELEBREX          1,997,616,682.32          200,550,827.23
\par                                             21    21 TRICOR            1,870,260,629.69          236,919,562.72
\par                                             22    22 FLUOXETINE        1,869,188,564.80          234,874,905.58
\par                                             23    23 ZETIA             1,854,446,393.75          200,993,518.88
\par                                             24    24 TOPAMAX           1,735,207,026.52          281,155,457.26
\par                                             25    25 FLOMAX            1,694,233,600.49          198,289,566.91
\par \page                                                     Task AH3.FD001: 2008 Prescribed Medicines Event PUF                17:57 Monday, September 20, 2010  11
\par 
\par                                                             QC testing for Z-Score computation
\par 
\par                                                                after re-arranging variables
\par 
\par Obs RANK1 RANK2 RANK3 RANK4 RANK5 RANK6 RANK7 RANK8 RANK9 RANK10 RANK11 RANK12 RANK13 RANK14 RANK15 RANK16 RANK17 RANK18 RANK19 RANK20 RANK21
\par 
\par  1    1     2     3     4     5     6     7     8     9     10     11     12     13     14     15     16     17     18     19     20     21
\par 
\par Obs RANK22 RANK23 RANK24 RANK25     STAT1        STAT2        STAT3        STAT4        STAT5        STAT6        STAT7        STAT8        STAT9
\par 
\par  1    22     23     24     25   9637282934.9 7540195953.3 5270883954.8 5263057480.3 4834909167.7 3896299732.6 3486593509.9 3459262683.3 3258483206.7
\par 
\par Obs    STAT10        STAT11        STAT12        STAT13        STAT14       STAT15       STAT16        STAT17        STAT18        STAT19        STAT20
\par 
\par  1  3026637828.6  2930929524.2  2550182267.6  2498042879.9  2447915296.2  2428735424  2421543723.9  2360616946.5  2027008378.6  2000885193.9  1997616682.3
\par 
\par Obs    STAT21       STAT22       STAT23       STAT24       STAT25         SE1          SE2          SE3          SE4          SE5          SE6
\par 
\par  1  1870260629.7 1869188564.8 1854446393.7 1735207026.5 1694233600.5 549978336.73 627466327.91 408912973.54 423242609.74 411850461.96 399168724.06
\par 
\par Obs      SE7          SE8          SE9         SE10         SE11         SE12         SE13         SE14         SE15         SE16         SE17
\par 
\par  1  293847051.63 363913378.63 278222841.31 395140493.47 263473713.63 235377992.53 244675502.82 564004308.64 354462837.64 223260928.94 270508386.83
\par 
\par Obs     SE18            SE19            SE20            SE21            SE22            SE23            SE24            SE25        NSTAT
\par 
\par  1  490477962.63    366744538.18    200550827.23    236919562.72    234874905.58    200993518.88    281155457.26    198289566.91      25
\par \page                                                     Task AH3.FD001: 2008 Prescribed Medicines Event PUF                17:57 Monday, September 20, 2010  12
\par 
\par                                            Z Scores to Compare Top 25 Drugs when Ranked by Weighted Expenditures
\par 
\par                                                                           Weighted                Weighted      SE of Weighted
\par                                                                       Expenditures            Expenditures        Expenditures
\par                             Drug #1          Drug #2                   for Drug #1             for Drug #2             Drug #1
\par 
\par                             1 LIPITOR        2 NEXIUM             9,637,282,934.88        7,540,195,953.25      549,978,336.73
\par                                              3 SIMVASTATIN        9,637,282,934.88        5,270,883,954.77      549,978,336.73
\par                                              4 ADVAIR             9,637,282,934.88        5,263,057,480.25      549,978,336.73
\par                                              5 PLAVIX             9,637,282,934.88        4,834,909,167.69      549,978,336.73
\par                                              6 ACTOS              9,637,282,934.88        3,896,299,732.58      549,978,336.73
\par                                              7 DIOVAN             9,637,282,934.88        3,486,593,509.85      549,978,336.73
\par                                              8 PREVACID           9,637,282,934.88        3,459,262,683.30      549,978,336.73
\par                                              9 SINGULAIR          9,637,282,934.88        3,258,483,206.67      549,978,336.73
\par                                              10 LANTUS            9,637,282,934.88        3,026,637,828.60      549,978,336.73
\par                                              11 CRESTOR           9,637,282,934.88        2,930,929,524.25      549,978,336.73
\par                                              12 VYTORIN           9,637,282,934.88        2,550,182,267.65      549,978,336.73
\par                                              13 EFFEXOR           9,637,282,934.88        2,498,042,879.88      549,978,336.73
\par                                              14 LAMICTAL          9,637,282,934.88        2,447,915,296.19      549,978,336.73
\par                                              15 ABILIFY           9,637,282,934.88        2,428,735,423.99      549,978,336.73
\par                                              16 LEXAPRO           9,637,282,934.88        2,421,543,723.92      549,978,336.73
\par                                              17 CYMBALTA          9,637,282,934.88        2,360,616,946.47      549,978,336.73
\par                                              18 PROVIGIL          9,637,282,934.88        2,027,008,378.60      549,978,336.73
\par                                              19 SEROQUEL          9,637,282,934.88        2,000,885,193.93      549,978,336.73
\par                                              20 CELEBREX          9,637,282,934.88        1,997,616,682.32      549,978,336.73
\par 
\par                                                SE of Weighted
\par                                                  Expenditures
\par                             Drug #1                   Drug #2           TOTAL1-TOTAL2              SESQRT    Z-SCORE    P-VALUE
\par 
\par                             1 LIPITOR          627,466,327.91        2,097,086,981.63      834,380,107.35     2.513      0.017
\par                                                408,912,973.54        4,366,398,980.11      685,336,407.03     6.371      <.001
\par                                                423,242,609.74        4,374,225,454.62      693,981,611.84     6.303      <.001
\par                                                411,850,461.96        4,802,373,767.19      687,093,133.34     6.989      <.001
\par                                                399,168,724.06        5,740,983,202.30      679,567,392.64     8.448      <.001
\par                                                293,847,051.63        6,150,689,425.03      623,556,140.72     9.864      <.001
\par                                                363,913,378.63        6,178,020,251.58      659,476,396.86     9.368      <.001
\par                                                278,222,841.31        6,378,799,728.21      616,347,402.28    10.349      <.001
\par                                                395,140,493.47        6,610,645,106.28      677,209,111.32     9.762      <.001
\par                                                263,473,713.63        6,706,353,410.63      609,831,590.40    10.997      <.001
\par                                                235,377,992.53        7,087,100,667.23      598,229,864.05    11.847      <.001
\par                                                244,675,502.82        7,139,240,055.00      601,948,729.17    11.860      <.001
\par                                                564,004,308.64        7,189,367,638.69      787,767,117.26     9.126      <.001
\par                                                354,462,837.64        7,208,547,510.89      654,308,852.26    11.017      <.001
\par                                                223,260,928.94        7,215,739,210.96      593,566,856.61    12.157      <.001
\par                                                270,508,386.83        7,276,665,988.41      612,903,710.40    11.872      <.001
\par                                                490,477,962.63        7,610,274,556.28      736,915,736.50    10.327      <.001
\par                                                366,744,538.18        7,636,397,740.95      661,042,908.71    11.552      <.001
\par                                                200,550,827.23        7,639,666,252.56      585,403,113.40    13.050      <.001
\par \page                                                     Task AH3.FD001: 2008 Prescribed Medicines Event PUF                17:57 Monday, September 20, 2010  13
\par 
\par                                            Z Scores to Compare Top 25 Drugs when Ranked by Weighted Expenditures
\par 
\par                                                                           Weighted                Weighted      SE of Weighted
\par                                                                       Expenditures            Expenditures        Expenditures
\par                             Drug #1          Drug #2                   for Drug #1             for Drug #2             Drug #1
\par 
\par                             1 LIPITOR        21 TRICOR            9,637,282,934.88        1,870,260,629.69      549,978,336.73
\par                                              22 FLUOXETINE        9,637,282,934.88        1,869,188,564.80      549,978,336.73
\par                                              23 ZETIA             9,637,282,934.88        1,854,446,393.75      549,978,336.73
\par                                              24 TOPAMAX           9,637,282,934.88        1,735,207,026.52      549,978,336.73
\par                                              25 FLOMAX            9,637,282,934.88        1,694,233,600.49      549,978,336.73
\par 
\par                                                SE of Weighted
\par                                                  Expenditures
\par                             Drug #1                   Drug #2           TOTAL1-TOTAL2              SESQRT    Z-SCORE    P-VALUE
\par 
\par                                                236,919,562.72        7,767,022,305.19      598,838,083.35    12.970      <.001
\par                                                234,874,905.58        7,768,094,370.08      598,032,099.59    12.989      <.001
\par                                                200,993,518.88        7,782,836,541.13      585,554,921.00    13.291      <.001
\par                                                281,155,457.26        7,902,075,908.36      617,676,745.57    12.793      <.001
\par                                                198,289,566.91        7,943,049,334.38      584,632,297.45    13.586      <.001
\par 
\par                                                                           Weighted                Weighted      SE of Weighted
\par                                                                       Expenditures            Expenditures        Expenditures
\par                             Drug #1          Drug #2                   for Drug #1             for Drug #2             Drug #1
\par 
\par                             2 NEXIUM         3 SIMVASTATIN        7,540,195,953.25        5,270,883,954.77      627,466,327.91
\par                                              4 ADVAIR             7,540,195,953.25        5,263,057,480.25      627,466,327.91
\par                                              5 PLAVIX             7,540,195,953.25        4,834,909,167.69      627,466,327.91
\par                                              6 ACTOS              7,540,195,953.25        3,896,299,732.58      627,466,327.91
\par                                              7 DIOVAN             7,540,195,953.25        3,486,593,509.85      627,466,327.91
\par                                              8 PREVACID           7,540,195,953.25        3,459,262,683.30      627,466,327.91
\par                                              9 SINGULAIR          7,540,195,953.25        3,258,483,206.67      627,466,327.91
\par                                              10 LANTUS            7,540,195,953.25        3,026,637,828.60      627,466,327.91
\par                                              11 CRESTOR           7,540,195,953.25        2,930,929,524.25      627,466,327.91
\par                                              12 VYTORIN           7,540,195,953.25        2,550,182,267.65      627,466,327.91
\par 
\par                                                SE of Weighted
\par                                                  Expenditures
\par                             Drug #1                   Drug #2           TOTAL1-TOTAL2              SESQRT    Z-SCORE    P-VALUE
\par 
\par                             2 NEXIUM           408,912,973.54        2,269,311,998.48      748,948,471.25     3.030      0.004
\par                                                423,242,609.74        2,277,138,473.00      756,867,425.22     3.009      0.004
\par                                                411,850,461.96        2,705,286,785.56      750,556,324.12     3.604      <.001
\par                                                399,168,724.06        3,643,896,220.67      743,673,088.75     4.900      <.001
\par                                                293,847,051.63        4,053,602,443.40      692,863,682.42     5.851      <.001
\par                                                363,913,378.63        4,080,933,269.95      725,359,869.17     5.626      <.001
\par                                                278,222,841.31        4,281,712,746.58      686,383,232.67     6.238      <.001
\par                                                395,140,493.47        4,513,558,124.65      741,518,713.35     6.087      <.001
\par                                                263,473,713.63        4,609,266,429.00      680,538,309.31     6.773      <.001
\par                                                235,377,992.53        4,990,013,685.60      670,161,765.57     7.446      <.001
\par \page                                                     Task AH3.FD001: 2008 Prescribed Medicines Event PUF                17:57 Monday, September 20, 2010  14
\par 
\par                                            Z Scores to Compare Top 25 Drugs when Ranked by Weighted Expenditures
\par 
\par                                                                           Weighted                Weighted      SE of Weighted
\par                                                                       Expenditures            Expenditures        Expenditures
\par                             Drug #1          Drug #2                   for Drug #1             for Drug #2             Drug #1
\par 
\par                             2 NEXIUM         13 EFFEXOR           7,540,195,953.25        2,498,042,879.88      627,466,327.91
\par                                              14 LAMICTAL          7,540,195,953.25        2,447,915,296.19      627,466,327.91
\par                                              15 ABILIFY           7,540,195,953.25        2,428,735,423.99      627,466,327.91
\par                                              16 LEXAPRO           7,540,195,953.25        2,421,543,723.92      627,466,327.91
\par                                              17 CYMBALTA          7,540,195,953.25        2,360,616,946.47      627,466,327.91
\par                                              18 PROVIGIL          7,540,195,953.25        2,027,008,378.60      627,466,327.91
\par                                              19 SEROQUEL          7,540,195,953.25        2,000,885,193.93      627,466,327.91
\par                                              20 CELEBREX          7,540,195,953.25        1,997,616,682.32      627,466,327.91
\par                                              21 TRICOR            7,540,195,953.25        1,870,260,629.69      627,466,327.91
\par                                              22 FLUOXETINE        7,540,195,953.25        1,869,188,564.80      627,466,327.91
\par                                              23 ZETIA             7,540,195,953.25        1,854,446,393.75      627,466,327.91
\par                                              24 TOPAMAX           7,540,195,953.25        1,735,207,026.52      627,466,327.91
\par                                              25 FLOMAX            7,540,195,953.25        1,694,233,600.49      627,466,327.91
\par 
\par                                                SE of Weighted
\par                                                  Expenditures
\par                             Drug #1                   Drug #2           TOTAL1-TOTAL2              SESQRT    Z-SCORE    P-VALUE
\par 
\par                                                244,675,502.82        5,042,153,073.37      673,483,551.65     7.487      <.001
\par                                                564,004,308.64        5,092,280,657.06      843,691,207.03     6.036      <.001
\par                                                354,462,837.64        5,111,460,529.26      720,664,898.50     7.093      <.001
\par                                                223,260,928.94        5,118,652,229.33      666,002,578.86     7.686      <.001
\par                                                270,508,386.83        5,179,579,006.78      683,292,602.05     7.580      <.001
\par                                                490,477,962.63        5,513,187,574.65      796,418,623.90     6.922      <.001
\par                                                366,744,538.18        5,539,310,759.32      726,784,389.59     7.622      <.001
\par                                                200,550,827.23        5,542,579,270.93      658,737,145.58     8.414      <.001
\par                                                236,919,562.72        5,669,935,323.56      670,704,757.60     8.454      <.001
\par                                                234,874,905.58        5,671,007,388.45      669,985,234.12     8.464      <.001
\par                                                200,993,518.88        5,685,749,559.50      658,872,056.85     8.630      <.001
\par                                                281,155,457.26        5,804,988,926.73      687,577,183.89     8.443      <.001
\par                                                198,289,566.91        5,845,962,352.76      658,052,235.77     8.884      <.001
\par 
\par                                                                           Weighted                Weighted      SE of Weighted
\par                                                                       Expenditures            Expenditures        Expenditures
\par                             Drug #1          Drug #2                   for Drug #1             for Drug #2             Drug #1
\par 
\par                             3 SIMVASTATIN    4 ADVAIR             5,270,883,954.77        5,263,057,480.25      408,912,973.54
\par                                              5 PLAVIX             5,270,883,954.77        4,834,909,167.69      408,912,973.54
\par 
\par                                                SE of Weighted
\par                                                  Expenditures
\par                             Drug #1                   Drug #2           TOTAL1-TOTAL2              SESQRT    Z-SCORE    P-VALUE
\par 
\par                             3 SIMVASTATIN      423,242,609.74            7,826,474.51      588,510,090.51     0.013      0.399
\par                                                411,850,461.96          435,974,787.08      580,371,107.95     0.751      0.301
\par \page                                                     Task AH3.FD001: 2008 Prescribed Medicines Event PUF                17:57 Monday, September 20, 2010  15
\par 
\par                                            Z Scores to Compare Top 25 Drugs when Ranked by Weighted Expenditures
\par 
\par                                                                           Weighted                Weighted      SE of Weighted
\par                                                                       Expenditures            Expenditures        Expenditures
\par                             Drug #1          Drug #2                   for Drug #1             for Drug #2             Drug #1
\par 
\par                             3 SIMVASTATIN    6 ACTOS              5,270,883,954.77        3,896,299,732.58      408,912,973.54
\par                                              7 DIOVAN             5,270,883,954.77        3,486,593,509.85      408,912,973.54
\par                                              8 PREVACID           5,270,883,954.77        3,459,262,683.30      408,912,973.54
\par                                              9 SINGULAIR          5,270,883,954.77        3,258,483,206.67      408,912,973.54
\par                                              10 LANTUS            5,270,883,954.77        3,026,637,828.60      408,912,973.54
\par                                              11 CRESTOR           5,270,883,954.77        2,930,929,524.25      408,912,973.54
\par                                              12 VYTORIN           5,270,883,954.77        2,550,182,267.65      408,912,973.54
\par                                              13 EFFEXOR           5,270,883,954.77        2,498,042,879.88      408,912,973.54
\par                                              14 LAMICTAL          5,270,883,954.77        2,447,915,296.19      408,912,973.54
\par                                              15 ABILIFY           5,270,883,954.77        2,428,735,423.99      408,912,973.54
\par                                              16 LEXAPRO           5,270,883,954.77        2,421,543,723.92      408,912,973.54
\par                                              17 CYMBALTA          5,270,883,954.77        2,360,616,946.47      408,912,973.54
\par                                              18 PROVIGIL          5,270,883,954.77        2,027,008,378.60      408,912,973.54
\par                                              19 SEROQUEL          5,270,883,954.77        2,000,885,193.93      408,912,973.54
\par                                              20 CELEBREX          5,270,883,954.77        1,997,616,682.32      408,912,973.54
\par                                              21 TRICOR            5,270,883,954.77        1,870,260,629.69      408,912,973.54
\par                                              22 FLUOXETINE        5,270,883,954.77        1,869,188,564.80      408,912,973.54
\par                                              23 ZETIA             5,270,883,954.77        1,854,446,393.75      408,912,973.54
\par                                              24 TOPAMAX           5,270,883,954.77        1,735,207,026.52      408,912,973.54
\par 
\par                                                SE of Weighted
\par                                                  Expenditures
\par                             Drug #1                   Drug #2           TOTAL1-TOTAL2              SESQRT    Z-SCORE    P-VALUE
\par 
\par                                                399,168,724.06        1,374,584,222.19      571,441,589.49     2.405      0.022
\par                                                293,847,051.63        1,784,290,444.91      503,543,354.32     3.543      <.001
\par                                                363,913,378.63        1,811,621,271.47      547,396,352.81     3.310      0.002
\par                                                278,222,841.31        2,012,400,748.09      494,588,484.86     4.069      <.001
\par                                                395,140,493.47        2,244,246,126.17      568,635,058.28     3.947      <.001
\par                                                263,473,713.63        2,339,954,430.52      486,444,465.17     4.810      <.001
\par                                                235,377,992.53        2,720,701,687.12      471,818,417.72     5.766      <.001
\par                                                244,675,502.82        2,772,841,074.89      476,524,838.40     5.819      <.001
\par                                                564,004,308.64        2,822,968,658.58      696,642,433.46     4.052      <.001
\par                                                354,462,837.64        2,842,148,530.78      541,159,609.72     5.252      <.001
\par                                                223,260,928.94        2,849,340,230.85      465,891,899.82     6.116      <.001
\par                                                270,508,386.83        2,910,267,008.30      490,290,329.57     5.936      <.001
\par                                                490,477,962.63        3,243,875,576.17      638,575,329.74     5.080      <.001
\par                                                366,744,538.18        3,269,998,760.84      549,282,601.41     5.953      <.001
\par                                                200,550,827.23        3,273,267,272.45      455,445,336.16     7.187      <.001
\par                                                236,919,562.72        3,400,623,325.08      472,589,355.71     7.196      <.001
\par                                                234,874,905.58        3,401,695,389.97      471,567,642.23     7.214      <.001
\par                                                200,993,518.88        3,416,437,561.02      455,640,444.39     7.498      <.001
\par                                                281,155,457.26        3,535,676,928.25      496,244,104.32     7.125      <.001
\par \page                                                     Task AH3.FD001: 2008 Prescribed Medicines Event PUF                17:57 Monday, September 20, 2010  16
\par 
\par                                            Z Scores to Compare Top 25 Drugs when Ranked by Weighted Expenditures
\par 
\par                                                                           Weighted                Weighted      SE of Weighted
\par                                                                       Expenditures            Expenditures        Expenditures
\par                             Drug #1          Drug #2                   for Drug #1             for Drug #2             Drug #1
\par 
\par                             3 SIMVASTATIN    25 FLOMAX            5,270,883,954.77        1,694,233,600.49      408,912,973.54
\par 
\par                                                SE of Weighted
\par                                                  Expenditures
\par                             Drug #1                   Drug #2           TOTAL1-TOTAL2              SESQRT    Z-SCORE    P-VALUE
\par 
\par                                                198,289,566.91        3,576,650,354.27      454,454,147.60     7.870      <.001
\par 
\par                                                                           Weighted                Weighted      SE of Weighted
\par                                                                       Expenditures            Expenditures        Expenditures
\par                             Drug #1          Drug #2                   for Drug #1             for Drug #2             Drug #1
\par 
\par                             4 ADVAIR         5 PLAVIX             5,263,057,480.25        4,834,909,167.69      423,242,609.74
\par                                              6 ACTOS              5,263,057,480.25        3,896,299,732.58      423,242,609.74
\par                                              7 DIOVAN             5,263,057,480.25        3,486,593,509.85      423,242,609.74
\par                                              8 PREVACID           5,263,057,480.25        3,459,262,683.30      423,242,609.74
\par                                              9 SINGULAIR          5,263,057,480.25        3,258,483,206.67      423,242,609.74
\par                                              10 LANTUS            5,263,057,480.25        3,026,637,828.60      423,242,609.74
\par                                              11 CRESTOR           5,263,057,480.25        2,930,929,524.25      423,242,609.74
\par                                              12 VYTORIN           5,263,057,480.25        2,550,182,267.65      423,242,609.74
\par                                              13 EFFEXOR           5,263,057,480.25        2,498,042,879.88      423,242,609.74
\par                                              14 LAMICTAL          5,263,057,480.25        2,447,915,296.19      423,242,609.74
\par                                              15 ABILIFY           5,263,057,480.25        2,428,735,423.99      423,242,609.74
\par                                              16 LEXAPRO           5,263,057,480.25        2,421,543,723.92      423,242,609.74
\par                                              17 CYMBALTA          5,263,057,480.25        2,360,616,946.47      423,242,609.74
\par                                              18 PROVIGIL          5,263,057,480.25        2,027,008,378.60      423,242,609.74
\par 
\par                                                SE of Weighted
\par                                                  Expenditures
\par                             Drug #1                   Drug #2           TOTAL1-TOTAL2              SESQRT    Z-SCORE    P-VALUE
\par 
\par                             4 ADVAIR           411,850,461.96          428,148,312.56      590,554,916.77     0.725      0.307
\par                                                399,168,724.06        1,366,757,747.68      581,781,726.22     2.349      0.025
\par                                                293,847,051.63        1,776,463,970.40      515,247,898.06     3.448      0.001
\par                                                363,913,378.63        1,803,794,796.95      558,182,097.39     3.232      0.002
\par                                                278,222,841.31        2,004,574,273.58      506,500,006.05     3.958      <.001
\par                                                395,140,493.47        2,236,419,651.66      579,025,315.75     3.862      <.001
\par                                                263,473,713.63        2,332,127,956.01      498,550,603.72     4.678      <.001
\par                                                235,377,992.53        2,712,875,212.61      484,290,311.77     5.602      <.001
\par                                                244,675,502.82        2,765,014,600.37      488,876,680.14     5.656      <.001
\par                                                564,004,308.64        2,815,142,184.07      705,149,038.76     3.992      <.001
\par                                                354,462,837.64        2,834,322,056.27      552,067,215.08     5.134      <.001
\par                                                223,260,928.94        2,841,513,756.33      478,518,285.01     5.938      <.001
\par                                                270,508,386.83        2,902,440,533.78      502,303,786.62     5.778      <.001
\par                                                490,477,962.63        3,236,049,101.66      647,844,841.40     4.995      <.001
\par \page                                                     Task AH3.FD001: 2008 Prescribed Medicines Event PUF                17:57 Monday, September 20, 2010  17
\par 
\par                                            Z Scores to Compare Top 25 Drugs when Ranked by Weighted Expenditures
\par 
\par                                                                           Weighted                Weighted      SE of Weighted
\par                                                                       Expenditures            Expenditures        Expenditures
\par                             Drug #1          Drug #2                   for Drug #1             for Drug #2             Drug #1
\par 
\par                             4 ADVAIR         19 SEROQUEL          5,263,057,480.25        2,000,885,193.93      423,242,609.74
\par                                              20 CELEBREX          5,263,057,480.25        1,997,616,682.32      423,242,609.74
\par                                              21 TRICOR            5,263,057,480.25        1,870,260,629.69      423,242,609.74
\par                                              22 FLUOXETINE        5,263,057,480.25        1,869,188,564.80      423,242,609.74
\par                                              23 ZETIA             5,263,057,480.25        1,854,446,393.75      423,242,609.74
\par                                              24 TOPAMAX           5,263,057,480.25        1,735,207,026.52      423,242,609.74
\par                                              25 FLOMAX            5,263,057,480.25        1,694,233,600.49      423,242,609.74
\par 
\par                                                SE of Weighted
\par                                                  Expenditures
\par                             Drug #1                   Drug #2           TOTAL1-TOTAL2              SESQRT    Z-SCORE    P-VALUE
\par 
\par                                                366,744,538.18        3,262,172,286.33      560,032,019.61     5.825      <.001
\par                                                200,550,827.23        3,265,440,797.93      468,353,435.99     6.972      <.001
\par                                                236,919,562.72        3,392,796,850.57      485,041,426.99     6.995      <.001
\par                                                234,874,905.58        3,393,868,915.45      484,045,997.79     7.011      <.001
\par                                                200,993,518.88        3,408,611,086.51      468,543,169.13     7.275      <.001
\par                                                281,155,457.26        3,527,850,453.73      508,116,815.16     6.943      <.001
\par                                                198,289,566.91        3,568,823,879.76      467,389,622.31     7.636      <.001
\par 
\par                                                                           Weighted                Weighted      SE of Weighted
\par                                                                       Expenditures            Expenditures        Expenditures
\par                             Drug #1          Drug #2                   for Drug #1             for Drug #2             Drug #1
\par 
\par                             5 PLAVIX         6 ACTOS              4,834,909,167.69        3,896,299,732.58      411,850,461.96
\par                                              7 DIOVAN             4,834,909,167.69        3,486,593,509.85      411,850,461.96
\par                                              8 PREVACID           4,834,909,167.69        3,459,262,683.30      411,850,461.96
\par                                              9 SINGULAIR          4,834,909,167.69        3,258,483,206.67      411,850,461.96
\par                                              10 LANTUS            4,834,909,167.69        3,026,637,828.60      411,850,461.96
\par                                              11 CRESTOR           4,834,909,167.69        2,930,929,524.25      411,850,461.96
\par                                              12 VYTORIN           4,834,909,167.69        2,550,182,267.65      411,850,461.96
\par                                              13 EFFEXOR           4,834,909,167.69        2,498,042,879.88      411,850,461.96
\par 
\par                                                SE of Weighted
\par                                                  Expenditures
\par                             Drug #1                   Drug #2           TOTAL1-TOTAL2              SESQRT    Z-SCORE    P-VALUE
\par 
\par                             5 PLAVIX           399,168,724.06          938,609,435.11      573,547,272.06     1.636      0.105
\par                                                293,847,051.63        1,348,315,657.84      505,931,707.61     2.665      0.011
\par                                                363,913,378.63        1,375,646,484.39      549,594,168.60     2.503      0.017
\par                                                278,222,841.31        1,576,425,961.02      497,019,871.27     3.172      0.003
\par                                                395,140,493.47        1,808,271,339.10      570,751,095.13     3.168      0.003
\par                                                263,473,713.63        1,903,979,643.44      488,916,353.57     3.894      <.001
\par                                                235,377,992.53        2,284,726,900.04      474,366,527.47     4.816      <.001
\par                                                244,675,502.82        2,336,866,287.81      479,047,914.82     4.878      <.001
\par \page                                                     Task AH3.FD001: 2008 Prescribed Medicines Event PUF                17:57 Monday, September 20, 2010  18
\par 
\par                                            Z Scores to Compare Top 25 Drugs when Ranked by Weighted Expenditures
\par 
\par                                                                           Weighted                Weighted      SE of Weighted
\par                                                                       Expenditures            Expenditures        Expenditures
\par                             Drug #1          Drug #2                   for Drug #1             for Drug #2             Drug #1
\par 
\par                             5 PLAVIX         14 LAMICTAL          4,834,909,167.69        2,447,915,296.19      411,850,461.96
\par                                              15 ABILIFY           4,834,909,167.69        2,428,735,423.99      411,850,461.96
\par                                              16 LEXAPRO           4,834,909,167.69        2,421,543,723.92      411,850,461.96
\par                                              17 CYMBALTA          4,834,909,167.69        2,360,616,946.47      411,850,461.96
\par                                              18 PROVIGIL          4,834,909,167.69        2,027,008,378.60      411,850,461.96
\par                                              19 SEROQUEL          4,834,909,167.69        2,000,885,193.93      411,850,461.96
\par                                              20 CELEBREX          4,834,909,167.69        1,997,616,682.32      411,850,461.96
\par                                              21 TRICOR            4,834,909,167.69        1,870,260,629.69      411,850,461.96
\par                                              22 FLUOXETINE        4,834,909,167.69        1,869,188,564.80      411,850,461.96
\par                                              23 ZETIA             4,834,909,167.69        1,854,446,393.75      411,850,461.96
\par                                              24 TOPAMAX           4,834,909,167.69        1,735,207,026.52      411,850,461.96
\par                                              25 FLOMAX            4,834,909,167.69        1,694,233,600.49      411,850,461.96
\par 
\par                                                SE of Weighted
\par                                                  Expenditures
\par                             Drug #1                   Drug #2           TOTAL1-TOTAL2              SESQRT    Z-SCORE    P-VALUE
\par 
\par                                                564,004,308.64        2,386,993,871.50      698,370,720.45     3.418      0.001
\par                                                354,462,837.64        2,406,173,743.70      543,382,651.81     4.428      <.001
\par                                                223,260,928.94        2,413,365,443.77      468,472,246.14     5.152      <.001
\par                                                270,508,386.83        2,474,292,221.22      492,742,925.23     5.021      <.001
\par                                                490,477,962.63        2,807,900,789.09      640,460,330.42     4.384      <.001
\par                                                366,744,538.18        2,834,023,973.76      551,472,899.88     5.139      <.001
\par                                                200,550,827.23        2,837,292,485.37      458,084,530.76     6.194      <.001
\par                                                236,919,562.72        2,964,648,538.00      475,133,330.99     6.240      <.001
\par                                                234,874,905.58        2,965,720,602.89      474,117,099.76     6.255      <.001
\par                                                200,993,518.88        2,980,462,773.94      458,278,515.37     6.504      <.001
\par                                                281,155,457.26        3,099,702,141.17      498,667,418.39     6.216      <.001
\par                                                198,289,566.91        3,140,675,567.20      457,099,065.15     6.871      <.001
\par 
\par                                                                           Weighted                Weighted      SE of Weighted
\par                                                                       Expenditures            Expenditures        Expenditures
\par                             Drug #1          Drug #2                   for Drug #1             for Drug #2             Drug #1
\par 
\par                             6 ACTOS          7 DIOVAN             3,896,299,732.58        3,486,593,509.85      399,168,724.06
\par                                              8 PREVACID           3,896,299,732.58        3,459,262,683.30      399,168,724.06
\par                                              9 SINGULAIR          3,896,299,732.58        3,258,483,206.67      399,168,724.06
\par 
\par                                                SE of Weighted
\par                                                  Expenditures
\par                             Drug #1                   Drug #2           TOTAL1-TOTAL2              SESQRT    Z-SCORE    P-VALUE
\par 
\par                             6 ACTOS            293,847,051.63          409,706,222.72      495,662,950.02     0.827      0.283
\par                                                363,913,378.63          437,037,049.27      540,156,104.67     0.809      0.288
\par                                                278,222,841.31          637,816,525.90      486,563,068.57     1.311      0.169
\par \page                                                     Task AH3.FD001: 2008 Prescribed Medicines Event PUF                17:57 Monday, September 20, 2010  19
\par 
\par                                            Z Scores to Compare Top 25 Drugs when Ranked by Weighted Expenditures
\par 
\par                                                                           Weighted                Weighted      SE of Weighted
\par                                                                       Expenditures            Expenditures        Expenditures
\par                             Drug #1          Drug #2                   for Drug #1             for Drug #2             Drug #1
\par 
\par                             6 ACTOS          10 LANTUS            3,896,299,732.58        3,026,637,828.60      399,168,724.06
\par                                              11 CRESTOR           3,896,299,732.58        2,930,929,524.25      399,168,724.06
\par                                              12 VYTORIN           3,896,299,732.58        2,550,182,267.65      399,168,724.06
\par                                              13 EFFEXOR           3,896,299,732.58        2,498,042,879.88      399,168,724.06
\par                                              14 LAMICTAL          3,896,299,732.58        2,447,915,296.19      399,168,724.06
\par                                              15 ABILIFY           3,896,299,732.58        2,428,735,423.99      399,168,724.06
\par                                              16 LEXAPRO           3,896,299,732.58        2,421,543,723.92      399,168,724.06
\par                                              17 CYMBALTA          3,896,299,732.58        2,360,616,946.47      399,168,724.06
\par                                              18 PROVIGIL          3,896,299,732.58        2,027,008,378.60      399,168,724.06
\par                                              19 SEROQUEL          3,896,299,732.58        2,000,885,193.93      399,168,724.06
\par                                              20 CELEBREX          3,896,299,732.58        1,997,616,682.32      399,168,724.06
\par                                              21 TRICOR            3,896,299,732.58        1,870,260,629.69      399,168,724.06
\par                                              22 FLUOXETINE        3,896,299,732.58        1,869,188,564.80      399,168,724.06
\par                                              23 ZETIA             3,896,299,732.58        1,854,446,393.75      399,168,724.06
\par                                              24 TOPAMAX           3,896,299,732.58        1,735,207,026.52      399,168,724.06
\par                                              25 FLOMAX            3,896,299,732.58        1,694,233,600.49      399,168,724.06
\par 
\par                                                SE of Weighted
\par                                                  Expenditures
\par                             Drug #1                   Drug #2           TOTAL1-TOTAL2              SESQRT    Z-SCORE    P-VALUE
\par 
\par                                                395,140,493.47          869,661,903.98      561,668,656.64     1.548      0.120
\par                                                263,473,713.63          965,370,208.33      478,282,414.52     2.018      0.052
\par                                                235,377,992.53        1,346,117,464.93      463,398,823.52     2.905      0.006
\par                                                244,675,502.82        1,398,256,852.69      468,189,888.77     2.987      0.005
\par                                                564,004,308.64        1,448,384,436.39      690,967,821.56     2.096      0.044
\par                                                354,462,837.64        1,467,564,308.59      533,834,781.12     2.749      0.009
\par                                                223,260,928.94        1,474,756,008.65      457,363,217.43     3.224      0.002
\par                                                270,508,386.83        1,535,682,786.10      482,193,381.97     3.185      0.003
\par                                                490,477,962.63        1,869,291,353.98      632,379,871.67     2.956      0.005
\par                                                366,744,538.18        1,895,414,538.65      542,067,547.96     3.497      <.001
\par                                                200,550,827.23        1,898,683,050.25      446,717,253.49     4.250      <.001
\par                                                236,919,562.72        2,026,039,102.89      464,183,745.37     4.365      <.001
\par                                                234,874,905.58        2,027,111,167.77      463,143,489.15     4.377      <.001
\par                                                200,993,518.88        2,041,853,338.83      446,916,172.12     4.569      <.001
\par                                                281,155,457.26        2,161,092,706.05      488,245,902.61     4.426      <.001
\par                                                198,289,566.91        2,202,066,132.08      445,706,655.34     4.941      <.001
\par \page                                                     Task AH3.FD001: 2008 Prescribed Medicines Event PUF                17:57 Monday, September 20, 2010  20
\par 
\par                                            Z Scores to Compare Top 25 Drugs when Ranked by Weighted Expenditures
\par 
\par                                                                           Weighted                Weighted      SE of Weighted
\par                                                                       Expenditures            Expenditures        Expenditures
\par                             Drug #1          Drug #2                   for Drug #1             for Drug #2             Drug #1
\par 
\par                             7 DIOVAN         8 PREVACID           3,486,593,509.85        3,459,262,683.30      293,847,051.63
\par                                              9 SINGULAIR          3,486,593,509.85        3,258,483,206.67      293,847,051.63
\par                                              10 LANTUS            3,486,593,509.85        3,026,637,828.60      293,847,051.63
\par                                              11 CRESTOR           3,486,593,509.85        2,930,929,524.25      293,847,051.63
\par                                              12 VYTORIN           3,486,593,509.85        2,550,182,267.65      293,847,051.63
\par                                              13 EFFEXOR           3,486,593,509.85        2,498,042,879.88      293,847,051.63
\par                                              14 LAMICTAL          3,486,593,509.85        2,447,915,296.19      293,847,051.63
\par                                              15 ABILIFY           3,486,593,509.85        2,428,735,423.99      293,847,051.63
\par                                              16 LEXAPRO           3,486,593,509.85        2,421,543,723.92      293,847,051.63
\par                                              17 CYMBALTA          3,486,593,509.85        2,360,616,946.47      293,847,051.63
\par                                              18 PROVIGIL          3,486,593,509.85        2,027,008,378.60      293,847,051.63
\par                                              19 SEROQUEL          3,486,593,509.85        2,000,885,193.93      293,847,051.63
\par                                              20 CELEBREX          3,486,593,509.85        1,997,616,682.32      293,847,051.63
\par                                              21 TRICOR            3,486,593,509.85        1,870,260,629.69      293,847,051.63
\par                                              22 FLUOXETINE        3,486,593,509.85        1,869,188,564.80      293,847,051.63
\par                                              23 ZETIA             3,486,593,509.85        1,854,446,393.75      293,847,051.63
\par                                              24 TOPAMAX           3,486,593,509.85        1,735,207,026.52      293,847,051.63
\par                                              25 FLOMAX            3,486,593,509.85        1,694,233,600.49      293,847,051.63
\par 
\par                                                SE of Weighted
\par                                                  Expenditures
\par                             Drug #1                   Drug #2           TOTAL1-TOTAL2              SESQRT    Z-SCORE    P-VALUE
\par 
\par                             7 DIOVAN           363,913,378.63           27,330,826.55      467,738,214.06     0.058      0.398
\par                                                278,222,841.31          228,110,303.18      404,665,342.20     0.564      0.340
\par                                                395,140,493.47          459,955,681.26      492,424,714.38     0.934      0.258
\par                                                263,473,713.63          555,663,985.61      394,670,099.61     1.408      0.148
\par                                                235,377,992.53          936,411,242.21      376,495,536.66     2.487      0.018
\par                                                244,675,502.82          988,550,629.97      382,377,027.86     2.585      0.014
\par                                                564,004,308.64        1,038,678,213.67      635,961,437.45     1.633      0.105
\par                                                354,462,837.64        1,057,858,085.87      460,423,710.32     2.298      0.028
\par                                                223,260,928.94        1,065,049,785.93      369,041,369.15     2.886      0.006
\par                                                270,508,386.83        1,125,976,563.38      399,400,647.35     2.819      0.008
\par                                                490,477,962.63        1,459,585,131.25      571,764,568.32     2.553      0.015
\par                                                366,744,538.18        1,485,708,315.93      469,944,300.99     3.161      0.003
\par                                                200,550,827.23        1,488,976,827.53      355,762,173.45     4.185      <.001
\par                                                236,919,562.72        1,616,332,880.17      377,461,215.16     4.282      <.001
\par                                                234,874,905.58        1,617,404,945.05      376,181,220.99     4.300      <.001
\par                                                200,993,518.88        1,632,147,116.11      356,011,916.07     4.585      <.001
\par                                                281,155,457.26        1,751,386,483.33      406,687,202.77     4.306      <.001
\par                                                198,289,566.91        1,792,359,909.36      354,492,372.41     5.056      <.001
\par \page                                                     Task AH3.FD001: 2008 Prescribed Medicines Event PUF                17:57 Monday, September 20, 2010  21
\par 
\par                                            Z Scores to Compare Top 25 Drugs when Ranked by Weighted Expenditures
\par 
\par                                                                           Weighted                Weighted      SE of Weighted
\par                                                                       Expenditures            Expenditures        Expenditures
\par                             Drug #1          Drug #2                   for Drug #1             for Drug #2             Drug #1
\par 
\par                             8 PREVACID       9 SINGULAIR          3,459,262,683.30        3,258,483,206.67      363,913,378.63
\par                                              10 LANTUS            3,459,262,683.30        3,026,637,828.60      363,913,378.63
\par                                              11 CRESTOR           3,459,262,683.30        2,930,929,524.25      363,913,378.63
\par                                              12 VYTORIN           3,459,262,683.30        2,550,182,267.65      363,913,378.63
\par                                              13 EFFEXOR           3,459,262,683.30        2,498,042,879.88      363,913,378.63
\par                                              14 LAMICTAL          3,459,262,683.30        2,447,915,296.19      363,913,378.63
\par                                              15 ABILIFY           3,459,262,683.30        2,428,735,423.99      363,913,378.63
\par                                              16 LEXAPRO           3,459,262,683.30        2,421,543,723.92      363,913,378.63
\par                                              17 CYMBALTA          3,459,262,683.30        2,360,616,946.47      363,913,378.63
\par                                              18 PROVIGIL          3,459,262,683.30        2,027,008,378.60      363,913,378.63
\par                                              19 SEROQUEL          3,459,262,683.30        2,000,885,193.93      363,913,378.63
\par                                              20 CELEBREX          3,459,262,683.30        1,997,616,682.32      363,913,378.63
\par                                              21 TRICOR            3,459,262,683.30        1,870,260,629.69      363,913,378.63
\par                                              22 FLUOXETINE        3,459,262,683.30        1,869,188,564.80      363,913,378.63
\par                                              23 ZETIA             3,459,262,683.30        1,854,446,393.75      363,913,378.63
\par                                              24 TOPAMAX           3,459,262,683.30        1,735,207,026.52      363,913,378.63
\par                                              25 FLOMAX            3,459,262,683.30        1,694,233,600.49      363,913,378.63
\par 
\par                                                SE of Weighted
\par                                                  Expenditures
\par                             Drug #1                   Drug #2           TOTAL1-TOTAL2              SESQRT    Z-SCORE    P-VALUE
\par 
\par                             8 PREVACID         278,222,841.31          200,779,476.63      458,083,940.53     0.438      0.362
\par                                                395,140,493.47          432,624,854.71      537,186,147.18     0.805      0.288
\par                                                263,473,713.63          528,333,159.05      449,278,694.04     1.176      0.200
\par                                                235,377,992.53          909,080,415.65      433,400,215.17     2.098      0.044
\par                                                244,675,502.82          961,219,803.42      438,519,154.45     2.192      0.036
\par                                                564,004,308.64        1,011,347,387.11      671,218,151.80     1.507      0.128
\par                                                354,462,837.64        1,030,527,259.31      508,012,647.88     2.029      0.051
\par                                                223,260,928.94        1,037,718,959.38      426,940,733.04     2.431      0.021
\par                                                270,508,386.83        1,098,645,736.83      453,439,890.71     2.423      0.021
\par                                                490,477,962.63        1,432,254,304.70      610,738,552.06     2.345      0.026
\par                                                366,744,538.18        1,458,377,489.37      516,657,046.24     2.823      0.007
\par                                                200,550,827.23        1,461,646,000.98      415,516,042.34     3.518      <.001
\par                                                236,919,562.72        1,589,002,053.62      434,239,365.26     3.659      <.001
\par                                                234,874,905.58        1,590,074,118.50      433,127,196.58     3.671      <.001
\par                                                200,993,518.88        1,604,816,289.55      415,729,890.40     3.860      <.001
\par                                                281,155,457.26        1,724,055,656.78      459,871,001.79     3.749      <.001
\par                                                198,289,566.91        1,765,029,082.81      414,429,366.10     4.259      <.001
\par \page                                                     Task AH3.FD001: 2008 Prescribed Medicines Event PUF                17:57 Monday, September 20, 2010  22
\par 
\par                                            Z Scores to Compare Top 25 Drugs when Ranked by Weighted Expenditures
\par 
\par                                                                           Weighted                Weighted      SE of Weighted
\par                                                                       Expenditures            Expenditures        Expenditures
\par                             Drug #1          Drug #2                   for Drug #1             for Drug #2             Drug #1
\par 
\par                             9 SINGULAIR      10 LANTUS            3,258,483,206.67        3,026,637,828.60      278,222,841.31
\par                                              11 CRESTOR           3,258,483,206.67        2,930,929,524.25      278,222,841.31
\par                                              12 VYTORIN           3,258,483,206.67        2,550,182,267.65      278,222,841.31
\par                                              13 EFFEXOR           3,258,483,206.67        2,498,042,879.88      278,222,841.31
\par                                              14 LAMICTAL          3,258,483,206.67        2,447,915,296.19      278,222,841.31
\par                                              15 ABILIFY           3,258,483,206.67        2,428,735,423.99      278,222,841.31
\par                                              16 LEXAPRO           3,258,483,206.67        2,421,543,723.92      278,222,841.31
\par                                              17 CYMBALTA          3,258,483,206.67        2,360,616,946.47      278,222,841.31
\par                                              18 PROVIGIL          3,258,483,206.67        2,027,008,378.60      278,222,841.31
\par                                              19 SEROQUEL          3,258,483,206.67        2,000,885,193.93      278,222,841.31
\par                                              20 CELEBREX          3,258,483,206.67        1,997,616,682.32      278,222,841.31
\par                                              21 TRICOR            3,258,483,206.67        1,870,260,629.69      278,222,841.31
\par                                              22 FLUOXETINE        3,258,483,206.67        1,869,188,564.80      278,222,841.31
\par                                              23 ZETIA             3,258,483,206.67        1,854,446,393.75      278,222,841.31
\par                                              24 TOPAMAX           3,258,483,206.67        1,735,207,026.52      278,222,841.31
\par                                              25 FLOMAX            3,258,483,206.67        1,694,233,600.49      278,222,841.31
\par 
\par                                                SE of Weighted
\par                                                  Expenditures
\par                             Drug #1                   Drug #2           TOTAL1-TOTAL2              SESQRT    Z-SCORE    P-VALUE
\par 
\par                             9 SINGULAIR        395,140,493.47          231,845,378.08      483,263,860.64     0.480      0.356
\par                                                263,473,713.63          327,553,682.43      383,179,262.48     0.855      0.277
\par                                                235,377,992.53          708,300,939.03      364,432,090.79     1.944      0.060
\par                                                244,675,502.82          760,440,326.79      370,505,129.66     2.052      0.049
\par                                                564,004,308.64          810,567,910.49      628,894,911.40     1.289      0.174
\par                                                354,462,837.64          829,747,782.69      450,612,752.47     1.841      0.073
\par                                                223,260,928.94          836,939,482.75      356,725,933.76     2.346      0.025
\par                                                270,508,386.83          897,866,260.20      388,049,915.31     2.314      0.027
\par                                                490,477,962.63        1,231,474,828.07      563,894,122.38     2.184      0.037
\par                                                366,744,538.18        1,257,598,012.75      460,336,296.32     2.732      0.010
\par                                                200,550,827.23        1,260,866,524.35      342,970,237.38     3.676      <.001
\par                                                236,919,562.72        1,388,222,576.99      365,429,649.35     3.799      <.001
\par                                                234,874,905.58        1,389,294,641.87      364,107,361.50     3.816      <.001
\par                                                200,993,518.88        1,404,036,812.93      343,229,287.88     4.091      <.001
\par                                                281,155,457.26        1,523,276,180.15      395,545,623.88     3.851      <.001
\par                                                198,289,566.91        1,564,249,606.18      341,652,896.62     4.578      <.001
\par \page                                                     Task AH3.FD001: 2008 Prescribed Medicines Event PUF                17:57 Monday, September 20, 2010  23
\par 
\par                                            Z Scores to Compare Top 25 Drugs when Ranked by Weighted Expenditures
\par 
\par                                                                           Weighted                Weighted      SE of Weighted
\par                                                                       Expenditures            Expenditures        Expenditures
\par                             Drug #1          Drug #2                   for Drug #1             for Drug #2             Drug #1
\par 
\par                             10 LANTUS        11 CRESTOR           3,026,637,828.60        2,930,929,524.25      395,140,493.47
\par                                              12 VYTORIN           3,026,637,828.60        2,550,182,267.65      395,140,493.47
\par                                              13 EFFEXOR           3,026,637,828.60        2,498,042,879.88      395,140,493.47
\par                                              14 LAMICTAL          3,026,637,828.60        2,447,915,296.19      395,140,493.47
\par                                              15 ABILIFY           3,026,637,828.60        2,428,735,423.99      395,140,493.47
\par                                              16 LEXAPRO           3,026,637,828.60        2,421,543,723.92      395,140,493.47
\par                                              17 CYMBALTA          3,026,637,828.60        2,360,616,946.47      395,140,493.47
\par                                              18 PROVIGIL          3,026,637,828.60        2,027,008,378.60      395,140,493.47
\par                                              19 SEROQUEL          3,026,637,828.60        2,000,885,193.93      395,140,493.47
\par                                              20 CELEBREX          3,026,637,828.60        1,997,616,682.32      395,140,493.47
\par                                              21 TRICOR            3,026,637,828.60        1,870,260,629.69      395,140,493.47
\par                                              22 FLUOXETINE        3,026,637,828.60        1,869,188,564.80      395,140,493.47
\par                                              23 ZETIA             3,026,637,828.60        1,854,446,393.75      395,140,493.47
\par                                              24 TOPAMAX           3,026,637,828.60        1,735,207,026.52      395,140,493.47
\par                                              25 FLOMAX            3,026,637,828.60        1,694,233,600.49      395,140,493.47
\par 
\par                                                SE of Weighted
\par                                                  Expenditures
\par                             Drug #1                   Drug #2           TOTAL1-TOTAL2              SESQRT    Z-SCORE    P-VALUE
\par 
\par                             10 LANTUS          263,473,713.63           95,708,304.35      474,925,686.14     0.202      0.391
\par                                                235,377,992.53          476,455,560.95      459,933,483.18     1.036      0.233
\par                                                244,675,502.82          528,594,948.71      464,760,272.89     1.137      0.209
\par                                                564,004,308.64          578,722,532.41      688,648,582.18     0.840      0.280
\par                                                354,462,837.64          597,902,404.61      530,829,457.40     1.126      0.212
\par                                                223,260,928.94          605,094,104.67      453,851,795.16     1.333      0.164
\par                                                270,508,386.83          666,020,882.12      478,864,069.36     1.391      0.152
\par                                                490,477,962.63          999,629,450.00      629,844,934.42     1.587      0.113
\par                                                366,744,538.18        1,025,752,634.67      539,108,120.75     1.903      0.065
\par                                                200,550,827.23        1,029,021,146.27      443,121,477.57     2.322      0.027
\par                                                236,919,562.72        1,156,377,198.91      460,724,308.87     2.510      0.017
\par                                                234,874,905.58        1,157,449,263.79      459,676,223.94     2.518      0.017
\par                                                200,993,518.88        1,172,191,434.85      443,322,009.62     2.644      0.012
\par                                                281,155,457.26        1,291,430,802.07      484,958,143.27     2.663      0.012
\par                                                198,289,566.91        1,332,404,228.10      442,102,659.94     3.014      0.004
\par \page                                                     Task AH3.FD001: 2008 Prescribed Medicines Event PUF                17:57 Monday, September 20, 2010  24
\par 
\par                                            Z Scores to Compare Top 25 Drugs when Ranked by Weighted Expenditures
\par 
\par                                                                           Weighted                Weighted      SE of Weighted
\par                                                                       Expenditures            Expenditures        Expenditures
\par                             Drug #1          Drug #2                   for Drug #1             for Drug #2             Drug #1
\par 
\par                             11 CRESTOR       12 VYTORIN           2,930,929,524.25        2,550,182,267.65      263,473,713.63
\par                                              13 EFFEXOR           2,930,929,524.25        2,498,042,879.88      263,473,713.63
\par                                              14 LAMICTAL          2,930,929,524.25        2,447,915,296.19      263,473,713.63
\par                                              15 ABILIFY           2,930,929,524.25        2,428,735,423.99      263,473,713.63
\par                                              16 LEXAPRO           2,930,929,524.25        2,421,543,723.92      263,473,713.63
\par                                              17 CYMBALTA          2,930,929,524.25        2,360,616,946.47      263,473,713.63
\par                                              18 PROVIGIL          2,930,929,524.25        2,027,008,378.60      263,473,713.63
\par                                              19 SEROQUEL          2,930,929,524.25        2,000,885,193.93      263,473,713.63
\par                                              20 CELEBREX          2,930,929,524.25        1,997,616,682.32      263,473,713.63
\par                                              21 TRICOR            2,930,929,524.25        1,870,260,629.69      263,473,713.63
\par                                              22 FLUOXETINE        2,930,929,524.25        1,869,188,564.80      263,473,713.63
\par                                              23 ZETIA             2,930,929,524.25        1,854,446,393.75      263,473,713.63
\par                                              24 TOPAMAX           2,930,929,524.25        1,735,207,026.52      263,473,713.63
\par                                              25 FLOMAX            2,930,929,524.25        1,694,233,600.49      263,473,713.63
\par 
\par                                                SE of Weighted
\par                                                  Expenditures
\par                             Drug #1                   Drug #2           TOTAL1-TOTAL2              SESQRT    Z-SCORE    P-VALUE
\par 
\par                             11 CRESTOR         235,377,992.53          380,747,256.60      353,300,434.68     1.078      0.223
\par                                                244,675,502.82          432,886,644.36      359,561,537.78     1.204      0.193
\par                                                564,004,308.64          483,014,228.06      622,510,448.05     0.776      0.295
\par                                                354,462,837.64          502,194,100.26      441,658,579.72     1.137      0.209
\par                                                223,260,928.94          509,385,800.33      345,345,971.69     1.475      0.134
\par                                                270,508,386.83          570,312,577.78      377,615,128.30     1.510      0.128
\par                                                490,477,962.63          903,921,145.65      556,764,788.40     1.624      0.107
\par                                                366,744,538.18          930,044,330.32      451,574,970.58     2.060      0.048
\par                                                200,550,827.23          933,312,841.92      331,117,852.24     2.819      0.008
\par                                                236,919,562.72        1,060,668,894.56      354,329,334.06     2.993      0.005
\par                                                234,874,905.58        1,061,740,959.44      352,965,464.38     3.008      0.004
\par                                                200,993,518.88        1,076,483,130.50      331,386,168.10     3.248      0.002
\par                                                281,155,457.26        1,195,722,497.73      385,313,883.63     3.103      0.003
\par                                                198,289,566.91        1,236,695,923.75      329,753,165.44     3.750      <.001
\par 
\par                                                                           Weighted                Weighted      SE of Weighted
\par                                                                       Expenditures            Expenditures        Expenditures
\par                             Drug #1          Drug #2                   for Drug #1             for Drug #2             Drug #1
\par 
\par                             12 VYTORIN       13 EFFEXOR           2,550,182,267.65        2,498,042,879.88      235,377,992.53
\par 
\par                                                SE of Weighted
\par                                                  Expenditures
\par                             Drug #1                   Drug #2           TOTAL1-TOTAL2              SESQRT    Z-SCORE    P-VALUE
\par 
\par                             12 VYTORIN         244,675,502.82           52,139,387.77      339,512,740.63     0.154      0.394
\par \page                                                     Task AH3.FD001: 2008 Prescribed Medicines Event PUF                17:57 Monday, September 20, 2010  25
\par 
\par                                            Z Scores to Compare Top 25 Drugs when Ranked by Weighted Expenditures
\par 
\par                                                                           Weighted                Weighted      SE of Weighted
\par                                                                       Expenditures            Expenditures        Expenditures
\par                             Drug #1          Drug #2                   for Drug #1             for Drug #2             Drug #1
\par 
\par                             12 VYTORIN       14 LAMICTAL          2,550,182,267.65        2,447,915,296.19      235,377,992.53
\par                                              15 ABILIFY           2,550,182,267.65        2,428,735,423.99      235,377,992.53
\par                                              16 LEXAPRO           2,550,182,267.65        2,421,543,723.92      235,377,992.53
\par                                              17 CYMBALTA          2,550,182,267.65        2,360,616,946.47      235,377,992.53
\par                                              18 PROVIGIL          2,550,182,267.65        2,027,008,378.60      235,377,992.53
\par                                              19 SEROQUEL          2,550,182,267.65        2,000,885,193.93      235,377,992.53
\par                                              20 CELEBREX          2,550,182,267.65        1,997,616,682.32      235,377,992.53
\par                                              21 TRICOR            2,550,182,267.65        1,870,260,629.69      235,377,992.53
\par                                              22 FLUOXETINE        2,550,182,267.65        1,869,188,564.80      235,377,992.53
\par                                              23 ZETIA             2,550,182,267.65        1,854,446,393.75      235,377,992.53
\par                                              24 TOPAMAX           2,550,182,267.65        1,735,207,026.52      235,377,992.53
\par                                              25 FLOMAX            2,550,182,267.65        1,694,233,600.49      235,377,992.53
\par 
\par                                                SE of Weighted
\par                                                  Expenditures
\par                             Drug #1                   Drug #2           TOTAL1-TOTAL2              SESQRT    Z-SCORE    P-VALUE
\par 
\par                                                564,004,308.64          102,266,971.46      611,149,457.61     0.167      0.393
\par                                                354,462,837.64          121,446,843.66      425,495,831.52     0.285      0.383
\par                                                223,260,928.94          128,638,543.73      324,419,854.14     0.397      0.369
\par                                                270,508,386.83          189,565,321.18      358,577,169.82     0.529      0.347
\par                                                490,477,962.63          523,173,889.05      544,032,564.47     0.962      0.251
\par                                                366,744,538.18          549,297,073.72      435,780,168.95     1.260      0.180
\par                                                200,550,827.23          552,565,585.33      309,230,389.31     1.787      0.081
\par                                                236,919,562.72          679,921,637.96      333,966,583.01     2.036      0.050
\par                                                234,874,905.58          680,993,702.85      332,519,203.42     2.048      0.049
\par                                                200,993,518.88          695,735,873.90      309,517,679.63     2.248      0.032
\par                                                281,155,457.26          814,975,241.13      366,675,865.74     2.223      0.034
\par                                                198,289,566.91          855,948,667.15      307,768,665.91     2.781      0.008
\par 
\par                                                                           Weighted                Weighted      SE of Weighted
\par                                                                       Expenditures            Expenditures        Expenditures
\par                             Drug #1          Drug #2                   for Drug #1             for Drug #2             Drug #1
\par 
\par                             13 EFFEXOR       14 LAMICTAL          2,498,042,879.88        2,447,915,296.19      244,675,502.82
\par                                              15 ABILIFY           2,498,042,879.88        2,428,735,423.99      244,675,502.82
\par                                              16 LEXAPRO           2,498,042,879.88        2,421,543,723.92      244,675,502.82
\par 
\par                                                SE of Weighted
\par                                                  Expenditures
\par                             Drug #1                   Drug #2           TOTAL1-TOTAL2              SESQRT    Z-SCORE    P-VALUE
\par 
\par                             13 EFFEXOR         564,004,308.64           50,127,583.70      614,790,177.09     0.082      0.398
\par                                                354,462,837.64           69,307,455.89      430,708,724.02     0.161      0.394
\par                                                223,260,928.94           76,499,155.96      331,227,329.90     0.231      0.388
\par \page                                                     Task AH3.FD001: 2008 Prescribed Medicines Event PUF                17:57 Monday, September 20, 2010  26
\par 
\par                                            Z Scores to Compare Top 25 Drugs when Ranked by Weighted Expenditures
\par 
\par                                                                           Weighted                Weighted      SE of Weighted
\par                                                                       Expenditures            Expenditures        Expenditures
\par                             Drug #1          Drug #2                   for Drug #1             for Drug #2             Drug #1
\par 
\par                             13 EFFEXOR       17 CYMBALTA          2,498,042,879.88        2,360,616,946.47      244,675,502.82
\par                                              18 PROVIGIL          2,498,042,879.88        2,027,008,378.60      244,675,502.82
\par                                              19 SEROQUEL          2,498,042,879.88        2,000,885,193.93      244,675,502.82
\par                                              20 CELEBREX          2,498,042,879.88        1,997,616,682.32      244,675,502.82
\par                                              21 TRICOR            2,498,042,879.88        1,870,260,629.69      244,675,502.82
\par                                              22 FLUOXETINE        2,498,042,879.88        1,869,188,564.80      244,675,502.82
\par                                              23 ZETIA             2,498,042,879.88        1,854,446,393.75      244,675,502.82
\par                                              24 TOPAMAX           2,498,042,879.88        1,735,207,026.52      244,675,502.82
\par                                              25 FLOMAX            2,498,042,879.88        1,694,233,600.49      244,675,502.82
\par 
\par                                                SE of Weighted
\par                                                  Expenditures
\par                             Drug #1                   Drug #2           TOTAL1-TOTAL2              SESQRT    Z-SCORE    P-VALUE
\par 
\par                                                270,508,386.83          137,425,933.41      364,747,706.00     0.377      0.372
\par                                                490,477,962.63          471,034,501.28      548,119,269.42     0.859      0.276
\par                                                366,744,538.18          497,157,685.96      440,871,475.56     1.128      0.211
\par                                                200,550,827.23          500,426,197.56      316,364,877.92     1.582      0.114
\par                                                236,919,562.72          627,782,250.20      340,583,295.07     1.843      0.073
\par                                                234,874,905.58          628,854,315.08      339,164,153.40     1.854      0.072
\par                                                200,993,518.88          643,596,486.14      316,645,695.24     2.033      0.051
\par                                                281,155,457.26          762,835,853.36      372,712,345.96     2.047      0.049
\par                                                198,289,566.91          803,809,279.39      314,936,269.78     2.552      0.015
\par 
\par                                                                           Weighted                Weighted      SE of Weighted
\par                                                                       Expenditures            Expenditures        Expenditures
\par                             Drug #1          Drug #2                   for Drug #1             for Drug #2             Drug #1
\par 
\par                             14 LAMICTAL      15 ABILIFY           2,447,915,296.19        2,428,735,423.99      564,004,308.64
\par                                              16 LEXAPRO           2,447,915,296.19        2,421,543,723.92      564,004,308.64
\par                                              17 CYMBALTA          2,447,915,296.19        2,360,616,946.47      564,004,308.64
\par                                              18 PROVIGIL          2,447,915,296.19        2,027,008,378.60      564,004,308.64
\par                                              19 SEROQUEL          2,447,915,296.19        2,000,885,193.93      564,004,308.64
\par                                              20 CELEBREX          2,447,915,296.19        1,997,616,682.32      564,004,308.64
\par 
\par                                                SE of Weighted
\par                                                  Expenditures
\par                             Drug #1                   Drug #2           TOTAL1-TOTAL2              SESQRT    Z-SCORE    P-VALUE
\par 
\par                             14 LAMICTAL        354,462,837.64           19,179,872.20      666,141,699.21     0.029      0.399
\par                                                223,260,928.94           26,371,572.26      606,585,775.10     0.043      0.399
\par                                                270,508,386.83           87,298,349.72      625,520,301.44     0.140      0.395
\par                                                490,477,962.63          420,906,917.59      747,441,965.64     0.563      0.340
\par                                                366,744,538.18          447,030,102.26      672,757,323.59     0.664      0.320
\par                                                200,550,827.23          450,298,613.86      598,599,611.15     0.752      0.301
\par \page                                                     Task AH3.FD001: 2008 Prescribed Medicines Event PUF                17:57 Monday, September 20, 2010  27
\par 
\par                                            Z Scores to Compare Top 25 Drugs when Ranked by Weighted Expenditures
\par 
\par                                                                           Weighted                Weighted      SE of Weighted
\par                                                                       Expenditures            Expenditures        Expenditures
\par                             Drug #1          Drug #2                   for Drug #1             for Drug #2             Drug #1
\par 
\par                             14 LAMICTAL      21 TRICOR            2,447,915,296.19        1,870,260,629.69      564,004,308.64
\par                                              22 FLUOXETINE        2,447,915,296.19        1,869,188,564.80      564,004,308.64
\par                                              23 ZETIA             2,447,915,296.19        1,854,446,393.75      564,004,308.64
\par                                              24 TOPAMAX           2,447,915,296.19        1,735,207,026.52      564,004,308.64
\par                                              25 FLOMAX            2,447,915,296.19        1,694,233,600.49      564,004,308.64
\par 
\par                                                SE of Weighted
\par                                                  Expenditures
\par                             Drug #1                   Drug #2           TOTAL1-TOTAL2              SESQRT    Z-SCORE    P-VALUE
\par 
\par                                                236,919,562.72          577,654,666.50      611,744,831.91     0.944      0.255
\par                                                234,874,905.58          578,726,731.38      610,955,875.20     0.947      0.255
\par                                                200,993,518.88          593,468,902.44      598,748,072.90     0.991      0.244
\par                                                281,155,457.26          712,708,269.67      630,197,787.45     1.131      0.210
\par                                                198,289,566.91          753,681,695.69      597,845,809.98     1.261      0.180
\par 
\par                                                                           Weighted                Weighted      SE of Weighted
\par                                                                       Expenditures            Expenditures        Expenditures
\par                             Drug #1          Drug #2                   for Drug #1             for Drug #2             Drug #1
\par 
\par                             15 ABILIFY       16 LEXAPRO           2,428,735,423.99        2,421,543,723.92      354,462,837.64
\par                                              17 CYMBALTA          2,428,735,423.99        2,360,616,946.47      354,462,837.64
\par                                              18 PROVIGIL          2,428,735,423.99        2,027,008,378.60      354,462,837.64
\par                                              19 SEROQUEL          2,428,735,423.99        2,000,885,193.93      354,462,837.64
\par                                              20 CELEBREX          2,428,735,423.99        1,997,616,682.32      354,462,837.64
\par                                              21 TRICOR            2,428,735,423.99        1,870,260,629.69      354,462,837.64
\par                                              22 FLUOXETINE        2,428,735,423.99        1,869,188,564.80      354,462,837.64
\par                                              23 ZETIA             2,428,735,423.99        1,854,446,393.75      354,462,837.64
\par                                              24 TOPAMAX           2,428,735,423.99        1,735,207,026.52      354,462,837.64
\par                                              25 FLOMAX            2,428,735,423.99        1,694,233,600.49      354,462,837.64
\par 
\par                                                SE of Weighted
\par                                                  Expenditures
\par                             Drug #1                   Drug #2           TOTAL1-TOTAL2              SESQRT    Z-SCORE    P-VALUE
\par 
\par                             15 ABILIFY         223,260,928.94            7,191,700.07      418,914,484.90     0.017      0.399
\par                                                270,508,386.83           68,118,477.52      445,890,895.42     0.153      0.394
\par                                                490,477,962.63          401,727,045.39      605,154,967.84     0.664      0.320
\par                                                366,744,538.18          427,850,230.06      510,044,566.24     0.839      0.281
\par                                                200,550,827.23          431,118,741.66      407,264,702.09     1.059      0.228
\par                                                236,919,562.72          558,474,794.30      426,350,539.42     1.310      0.169
\par                                                234,874,905.58          559,546,859.18      425,217,737.80     1.316      0.168
\par                                                200,993,518.88          574,289,030.24      407,482,880.50     1.409      0.148
\par                                                281,155,457.26          693,528,397.47      452,429,325.33     1.533      0.123
\par                                                198,289,566.91          734,501,823.49      406,155,949.87     1.808      0.078
\par \page                                                     Task AH3.FD001: 2008 Prescribed Medicines Event PUF                17:57 Monday, September 20, 2010  28
\par 
\par                                            Z Scores to Compare Top 25 Drugs when Ranked by Weighted Expenditures
\par 
\par                                                                           Weighted                Weighted      SE of Weighted
\par                                                                       Expenditures            Expenditures        Expenditures
\par                             Drug #1          Drug #2                   for Drug #1             for Drug #2             Drug #1
\par 
\par                             16 LEXAPRO       17 CYMBALTA          2,421,543,723.92        2,360,616,946.47      223,260,928.94
\par                                              18 PROVIGIL          2,421,543,723.92        2,027,008,378.60      223,260,928.94
\par                                              19 SEROQUEL          2,421,543,723.92        2,000,885,193.93      223,260,928.94
\par                                              20 CELEBREX          2,421,543,723.92        1,997,616,682.32      223,260,928.94
\par                                              21 TRICOR            2,421,543,723.92        1,870,260,629.69      223,260,928.94
\par                                              22 FLUOXETINE        2,421,543,723.92        1,869,188,564.80      223,260,928.94
\par                                              23 ZETIA             2,421,543,723.92        1,854,446,393.75      223,260,928.94
\par                                              24 TOPAMAX           2,421,543,723.92        1,735,207,026.52      223,260,928.94
\par                                              25 FLOMAX            2,421,543,723.92        1,694,233,600.49      223,260,928.94
\par 
\par                                                SE of Weighted
\par                                                  Expenditures
\par                             Drug #1                   Drug #2           TOTAL1-TOTAL2              SESQRT    Z-SCORE    P-VALUE
\par 
\par                             16 LEXAPRO         270,508,386.83           60,926,777.45      350,742,397.97     0.174      0.393
\par                                                490,477,962.63          394,535,345.32      538,900,801.84     0.732      0.305
\par                                                366,744,538.18          420,658,530.00      429,356,493.69     0.980      0.247
\par                                                200,550,827.23          423,927,041.60      300,110,107.61     1.413      0.147
\par                                                236,919,562.72          551,283,094.24      325,540,046.06     1.693      0.095
\par                                                234,874,905.58          552,355,159.12      324,055,031.84     1.705      0.093
\par                                                200,993,518.88          567,097,330.17      300,406,120.15     1.888      0.067
\par                                                281,155,457.26          686,336,697.40      359,017,873.56     1.912      0.064
\par                                                198,289,566.91          727,310,123.43      298,603,742.00     2.436      0.021
\par 
\par                                                                           Weighted                Weighted      SE of Weighted
\par                                                                       Expenditures            Expenditures        Expenditures
\par                             Drug #1          Drug #2                   for Drug #1             for Drug #2             Drug #1
\par 
\par                             17 CYMBALTA      18 PROVIGIL          2,360,616,946.47        2,027,008,378.60      270,508,386.83
\par                                              19 SEROQUEL          2,360,616,946.47        2,000,885,193.93      270,508,386.83
\par                                              20 CELEBREX          2,360,616,946.47        1,997,616,682.32      270,508,386.83
\par                                              21 TRICOR            2,360,616,946.47        1,870,260,629.69      270,508,386.83
\par                                              22 FLUOXETINE        2,360,616,946.47        1,869,188,564.80      270,508,386.83
\par                                              23 ZETIA             2,360,616,946.47        1,854,446,393.75      270,508,386.83
\par 
\par                                                SE of Weighted
\par                                                  Expenditures
\par                             Drug #1                   Drug #2           TOTAL1-TOTAL2              SESQRT    Z-SCORE    P-VALUE
\par 
\par                             17 CYMBALTA        490,477,962.63          333,608,567.87      560,128,038.20     0.596      0.334
\par                                                366,744,538.18          359,731,752.54      455,715,200.13     0.789      0.292
\par                                                200,550,827.23          363,000,264.15      336,742,366.88     1.078      0.223
\par                                                236,919,562.72          490,356,316.79      359,590,971.17     1.364      0.157
\par                                                234,874,905.58          491,428,381.67      358,247,133.44     1.372      0.156
\par                                                200,993,518.88          506,170,552.72      337,006,204.66     1.502      0.129
\par \page                                                     Task AH3.FD001: 2008 Prescribed Medicines Event PUF                17:57 Monday, September 20, 2010  29
\par 
\par                                            Z Scores to Compare Top 25 Drugs when Ranked by Weighted Expenditures
\par 
\par                                                                           Weighted                Weighted      SE of Weighted
\par                                                                       Expenditures            Expenditures        Expenditures
\par                             Drug #1          Drug #2                   for Drug #1             for Drug #2             Drug #1
\par 
\par                             17 CYMBALTA      24 TOPAMAX           2,360,616,946.47        1,735,207,026.52      270,508,386.83
\par                                              25 FLOMAX            2,360,616,946.47        1,694,233,600.49      270,508,386.83
\par 
\par                                                SE of Weighted
\par                                                  Expenditures
\par                             Drug #1                   Drug #2           TOTAL1-TOTAL2              SESQRT    Z-SCORE    P-VALUE
\par 
\par                                                281,155,457.26          625,409,919.95      390,157,889.19     1.603      0.110
\par                                                198,289,566.91          666,383,345.98      335,400,566.03     1.987      0.055
\par 
\par                                                                           Weighted                Weighted      SE of Weighted
\par                                                                       Expenditures            Expenditures        Expenditures
\par                             Drug #1          Drug #2                   for Drug #1             for Drug #2             Drug #1
\par 
\par                             18 PROVIGIL      19 SEROQUEL          2,027,008,378.60        2,000,885,193.93      490,477,962.63
\par                                              20 CELEBREX          2,027,008,378.60        1,997,616,682.32      490,477,962.63
\par                                              21 TRICOR            2,027,008,378.60        1,870,260,629.69      490,477,962.63
\par                                              22 FLUOXETINE        2,027,008,378.60        1,869,188,564.80      490,477,962.63
\par                                              23 ZETIA             2,027,008,378.60        1,854,446,393.75      490,477,962.63
\par                                              24 TOPAMAX           2,027,008,378.60        1,735,207,026.52      490,477,962.63
\par                                              25 FLOMAX            2,027,008,378.60        1,694,233,600.49      490,477,962.63
\par 
\par                                                SE of Weighted
\par                                                  Expenditures
\par                             Drug #1                   Drug #2           TOTAL1-TOTAL2              SESQRT    Z-SCORE    P-VALUE
\par 
\par                             18 PROVIGIL        366,744,538.18           26,123,184.67      612,429,741.37     0.043      0.399
\par                                                200,550,827.23           29,391,696.28      529,895,523.79     0.055      0.398
\par                                                236,919,562.72          156,747,748.91      544,701,304.41     0.288      0.383
\par                                                234,874,905.58          157,819,813.80      543,815,090.91     0.290      0.382
\par                                                200,993,518.88          172,561,984.85      530,063,228.74     0.326      0.378
\par                                                281,155,457.26          291,801,352.08      565,346,816.54     0.516      0.349
\par                                                198,289,566.91          332,774,778.10      529,043,839.56     0.629      0.327
\par 
\par                                                                           Weighted                Weighted      SE of Weighted
\par                                                                       Expenditures            Expenditures        Expenditures
\par                             Drug #1          Drug #2                   for Drug #1             for Drug #2             Drug #1
\par 
\par                             19 SEROQUEL      20 CELEBREX          2,000,885,193.93        1,997,616,682.32      366,744,538.18
\par 
\par                                                SE of Weighted
\par                                                  Expenditures
\par                             Drug #1                   Drug #2           TOTAL1-TOTAL2              SESQRT    Z-SCORE    P-VALUE
\par 
\par                             19 SEROQUEL        200,550,827.23            3,268,511.60      417,997,835.62     0.008      0.399
\par \page                                                     Task AH3.FD001: 2008 Prescribed Medicines Event PUF                17:57 Monday, September 20, 2010  30
\par 
\par                                            Z Scores to Compare Top 25 Drugs when Ranked by Weighted Expenditures
\par 
\par                                                                           Weighted                Weighted      SE of Weighted
\par                                                                       Expenditures            Expenditures        Expenditures
\par                             Drug #1          Drug #2                   for Drug #1             for Drug #2             Drug #1
\par 
\par                             19 SEROQUEL      21 TRICOR            2,000,885,193.93        1,870,260,629.69      366,744,538.18
\par                                              22 FLUOXETINE        2,000,885,193.93        1,869,188,564.80      366,744,538.18
\par                                              23 ZETIA             2,000,885,193.93        1,854,446,393.75      366,744,538.18
\par                                              24 TOPAMAX           2,000,885,193.93        1,735,207,026.52      366,744,538.18
\par                                              25 FLOMAX            2,000,885,193.93        1,694,233,600.49      366,744,538.18
\par 
\par                                                SE of Weighted
\par                                                  Expenditures
\par                             Drug #1                   Drug #2           TOTAL1-TOTAL2              SESQRT    Z-SCORE    P-VALUE
\par 
\par                                                236,919,562.72          130,624,564.24      436,614,744.92     0.299      0.381
\par                                                234,874,905.58          131,696,629.12      435,508,642.34     0.302      0.381
\par                                                200,993,518.88          146,438,800.18      418,210,414.64     0.350      0.375
\par                                                281,155,457.26          265,678,167.41      462,114,647.50     0.575      0.338
\par                                                198,289,566.91          306,651,593.43      416,917,628.11     0.736      0.304
\par 
\par                                                                           Weighted                Weighted      SE of Weighted
\par                                                                       Expenditures            Expenditures        Expenditures
\par                             Drug #1          Drug #2                   for Drug #1             for Drug #2             Drug #1
\par 
\par                             20 CELEBREX      21 TRICOR            1,997,616,682.32        1,870,260,629.69      200,550,827.23
\par                                              22 FLUOXETINE        1,997,616,682.32        1,869,188,564.80      200,550,827.23
\par                                              23 ZETIA             1,997,616,682.32        1,854,446,393.75      200,550,827.23
\par                                              24 TOPAMAX           1,997,616,682.32        1,735,207,026.52      200,550,827.23
\par                                              25 FLOMAX            1,997,616,682.32        1,694,233,600.49      200,550,827.23
\par 
\par                                                SE of Weighted
\par                                                  Expenditures
\par                             Drug #1                   Drug #2           TOTAL1-TOTAL2              SESQRT    Z-SCORE    P-VALUE
\par 
\par                             20 CELEBREX        236,919,562.72          127,356,052.64      310,405,401.86     0.410      0.367
\par                                                234,874,905.58          128,428,117.52      308,847,625.17     0.416      0.366
\par                                                200,993,518.88          143,170,288.58      283,934,902.64     0.504      0.351
\par                                                281,155,457.26          262,409,655.80      345,353,478.99     0.760      0.299
\par                                                198,289,566.91          303,383,081.83      282,027,279.97     1.076      0.224
\par \page                                                     Task AH3.FD001: 2008 Prescribed Medicines Event PUF                17:57 Monday, September 20, 2010  31
\par 
\par                                            Z Scores to Compare Top 25 Drugs when Ranked by Weighted Expenditures
\par 
\par                                                                           Weighted                Weighted      SE of Weighted
\par                                                                       Expenditures            Expenditures        Expenditures
\par                             Drug #1          Drug #2                   for Drug #1             for Drug #2             Drug #1
\par 
\par                             21 TRICOR        22 FLUOXETINE        1,870,260,629.69        1,869,188,564.80      236,919,562.72
\par                                              23 ZETIA             1,870,260,629.69        1,854,446,393.75      236,919,562.72
\par                                              24 TOPAMAX           1,870,260,629.69        1,735,207,026.52      236,919,562.72
\par                                              25 FLOMAX            1,870,260,629.69        1,694,233,600.49      236,919,562.72
\par 
\par                                                SE of Weighted
\par                                                  Expenditures
\par                             Drug #1                   Drug #2           TOTAL1-TOTAL2              SESQRT    Z-SCORE    P-VALUE
\par 
\par                             21 TRICOR          234,874,905.58            1,072,064.88      333,612,200.72     0.003      0.399
\par                                                200,993,518.88           15,814,235.94      310,691,605.67     0.051      0.398
\par                                                281,155,457.26          135,053,603.16      367,667,336.52     0.367      0.373
\par                                                198,289,566.91          176,027,029.19      308,949,237.81     0.570      0.339
\par 
\par                                                                           Weighted                Weighted      SE of Weighted
\par                                                                       Expenditures            Expenditures        Expenditures
\par                             Drug #1          Drug #2                   for Drug #1             for Drug #2             Drug #1
\par 
\par                             22 FLUOXETINE    23 ZETIA             1,869,188,564.80        1,854,446,393.75      234,874,905.58
\par                                              24 TOPAMAX           1,869,188,564.80        1,735,207,026.52      234,874,905.58
\par                                              25 FLOMAX            1,869,188,564.80        1,694,233,600.49      234,874,905.58
\par 
\par                                                SE of Weighted
\par                                                  Expenditures
\par                             Drug #1                   Drug #2           TOTAL1-TOTAL2              SESQRT    Z-SCORE    P-VALUE
\par 
\par                             22 FLUOXETINE      200,993,518.88           14,742,171.06      309,135,271.21     0.048      0.398
\par                                                281,155,457.26          133,981,538.28      366,353,125.30     0.366      0.373
\par                                                198,289,566.91          174,954,964.31      307,384,081.59     0.569      0.339
\par 
\par                                                                           Weighted                Weighted      SE of Weighted
\par                                                                       Expenditures            Expenditures        Expenditures
\par                             Drug #1          Drug #2                   for Drug #1             for Drug #2             Drug #1
\par 
\par                             23 ZETIA         24 TOPAMAX           1,854,446,393.75        1,735,207,026.52      200,993,518.88
\par                                              25 FLOMAX            1,854,446,393.75        1,694,233,600.49      200,993,518.88
\par 
\par                                                SE of Weighted
\par                                                  Expenditures
\par                             Drug #1                   Drug #2           TOTAL1-TOTAL2              SESQRT    Z-SCORE    P-VALUE
\par 
\par                             23 ZETIA           281,155,457.26          119,239,367.23      345,610,743.15     0.345      0.376
\par                                                198,289,566.91          160,212,793.25      282,342,251.49     0.567      0.340
\par \page                                                     Task AH3.FD001: 2008 Prescribed Medicines Event PUF                17:57 Monday, September 20, 2010  32
\par 
\par                                            Z Scores to Compare Top 25 Drugs when Ranked by Weighted Expenditures
\par 
\par                                                                           Weighted                Weighted      SE of Weighted
\par                                                                       Expenditures            Expenditures        Expenditures
\par                             Drug #1          Drug #2                   for Drug #1             for Drug #2             Drug #1
\par 
\par                             24 TOPAMAX       25 FLOMAX            1,735,207,026.52        1,694,233,600.49      281,155,457.26
\par 
\par                                                SE of Weighted
\par                                                  Expenditures
\par                             Drug #1                   Drug #2           TOTAL1-TOTAL2              SESQRT    Z-SCORE    P-VALUE
\par 
\par                             24 TOPAMAX         198,289,566.91           40,973,426.03      344,045,263.73     0.119      0.396
}
